{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T12:10:06Z","timestamp":1756728606800,"version":"3.44.0"},"reference-count":672,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.gofs.2025.07.005","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T06:48:52Z","timestamp":1752734932000},"page":"365-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Le cancer du col de l\u2019ut\u00e9rus\u00a0: recommandations pour la pratique clinique"],"prefix":"10.1016","volume":"53","author":[{"given":"Xavier","family":"Carcopino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lobna","family":"Ouldamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrille","family":"Huchon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Asseeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Aza\u00efs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofiane","family":"Bendifallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Brun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffroy","family":"Canlorbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Chauvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abel","family":"Cordoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Courcier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohann","family":"Dabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"de Berti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Diguisto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristan","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Witold","family":"Gertych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Gladieff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Graesslin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohan","family":"Kerbage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Koskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enora","family":"Laas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aymeline","family":"Lacorre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Lavou\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Lecointre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Lecuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Margueritte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul-Jean","family":"Maternowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Mathevet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imane","family":"Menouer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Mimoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Moureau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Netter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles-Andr\u00e9","family":"Philip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Sanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Thomassin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Touboul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Lev\u00eaque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2025.07.005_bib0005","first-page":"189","article-title":"Incidence des principaux cancers en France m\u00e9tropolitaine en 2023 et tendances depuis 1990 [Internet]","volume":"12\u201313","author":"Lap\u00f4tre-Ledoux","year":"2023","journal-title":"Bull Epidemiol Hebd (Paris)"},{"year":"2024","series-title":"Panorama des cancers en France\u00a0\u2013\u00a0\u00e9dition 2024 [Internet]","key":"10.1016\/j.gofs.2025.07.005_bib0010"},{"year":"2019","series-title":"\u00c9valuation de la recherche des papillomavirus humains (HPV) en d\u00e9pistage primaire des l\u00e9sions pr\u00e9canc\u00e9reuses et canc\u00e9reuses du col de l\u2019ut\u00e9rus et de la place du double immuno-marquage p16\/Ki67 [internet]","key":"10.1016\/j.gofs.2025.07.005_bib0015"},{"year":"2019","series-title":"Recommandation sur l\u2019\u00e9largissement de la vaccination contre les papillomavirus aux gar\u00e7ons [Internet]","key":"10.1016\/j.gofs.2025.07.005_bib0020"},{"year":"2025","series-title":"Bilan de la campagne de vaccination contre les infections a papillomavirus humain (HPV) men\u00e9e au coll\u00e8ge dans les classes de 5e au cours de l\u2019ann\u00e9e scolaire 2023\u20132024 en France [Internet]","key":"10.1016\/j.gofs.2025.07.005_bib0025"},{"issue":"14","key":"10.1016\/j.gofs.2025.07.005_bib0030","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"issue":"10316","key":"10.1016\/j.gofs.2025.07.005_bib0035","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0045","first-page":"3","article-title":"Recommandations pour la pratique clinique du CNGOF\u00a0: r\u00e9vision m\u00e9thodologique du processus d\u2019\u00e9laboration","volume":"48","author":"Schmitz","year":"2020","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0050","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1006\/gyno.2000.5986","article-title":"Effect of MRI on therapeutic decisions in invasive cervical carcinoma. Direct comparison with the pelvic examination as a preperative test","volume":"79","author":"Postema","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib0055","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1007\/s00330-003-1928-2","article-title":"The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma","volume":"13","author":"Ozsarlak","year":"2003","journal-title":"Eur Radiol"},{"issue":"36","key":"10.1016\/j.gofs.2025.07.005_bib0060","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1200\/JCO.2005.02.0354","article-title":"Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183","volume":"23","author":"Hricak","year":"2005","journal-title":"J Clin Oncol"},{"issue":"36","key":"10.1016\/j.gofs.2025.07.005_bib0065","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1200\/JCO.2006.07.4799","article-title":"Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651\/GOG 183 Intergroup Study","volume":"24","author":"Mitchell","year":"2006","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib0070","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/jjco\/hym036","article-title":"Can preoperative MRI accurately evaluate nodal and parametrial invasion in early stage cervical cancer?","volume":"37","author":"Chung","year":"2007","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/IGC.0b013e31827a4ad8","article-title":"The negative predictive value of clinical examination with or without anesthesia versus magnetic resonance imaging for parametrial infiltration in cervical cancer stages IB1 to IIA","volume":"23","author":"Bleker","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0080","first-page":"561","article-title":"Primary uterine cervical cancer: correlation of preoperative magnetic resonance imaging and clinical staging (FIGO) with histopathology findings","volume":"37","author":"Kraljevi\u0107","year":"2013","journal-title":"Coll Antropol"},{"key":"10.1016\/j.gofs.2025.07.005_bib0085","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00330-013-2783-4","article-title":"Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: systematic review and meta-analysis","volume":"23","author":"Thomeer","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.gofs.2025.07.005_bib0090","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.2147\/CMAR.S197496","article-title":"Impact of pelvic MRI in routine clinical practice on staging of IB1-IIA2 cervical cancer","volume":"11","author":"Zhang","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ygyno.2020.07.007","article-title":"Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging\u00a0\u2013\u00a0an analysis from the EMBRACE study","volume":"159","author":"Knoth","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib0100","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.3390\/cancers13122961","article-title":"The importance of clinical examination under general anesthesia: improving parametrial assessment in cervical cancer patients","volume":"13","author":"Sodeikat","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib0105","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1007\/s003300000774","article-title":"Preoperative staging of cervical carcinoma with MR imaging: a reappraisal of diagnostic accuracy and pitfalls","volume":"11","author":"Sheu","year":"2001","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib0110","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.rct.0000138007.77725.0a","article-title":"Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: results of prospective study","volume":"28","author":"Choi","year":"2004","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2005.10.012","article-title":"Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?","volume":"101","author":"Rockall","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib0120","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1245\/s10434-008-0088-7","article-title":"Pretreatment staging of cervical cancer: is imaging better than palpation?","volume":"15","author":"Hancke","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"30","key":"10.1016\/j.gofs.2025.07.005_bib0125","doi-asserted-by":"crossref","first-page":"7454","DOI":"10.1200\/JCO.2004.00.5397","article-title":"Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651\/GOG 183","volume":"23","author":"Amendola","year":"2005","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib0130","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0002-9378(72)90660-6","article-title":"The effect of examination under anesthesia on staging accuracy in cervical cancer","volume":"113","author":"Van Nagell","year":"1972","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2018.03.056","article-title":"The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: a systematic review and meta-analysis","volume":"150","author":"Charakorn","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0140","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/ijgc-00009577-200605000-00023","article-title":"The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy","volume":"16","author":"Ogino","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib0145","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5468\/ogs.2015.58.5.368","article-title":"The prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients","volume":"58","author":"Ryu","year":"2015","journal-title":"Obstet Gynecol Sci"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/gyno.1994.1012","article-title":"The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix","volume":"52","author":"Ngan","year":"1994","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000010257","article-title":"Prognostic value of p53 expression in stage IB1 cervical carcinoma","volume":"49","author":"Chen","year":"2000","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib0160","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1136\/ijgc-00009577-200609000-00019","article-title":"Impact of hemoglobin on survival of cervical carcinoma patients treated with concurrent chemoradiotherapy is dependent on lymph node metastasis findings by magnetic resonance imaging","volume":"16","author":"Choi","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib0165","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/sj.bjc.6604661","article-title":"Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer","volume":"99","author":"Huang","year":"2008","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0170","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ijrobp.2010.07.011","article-title":"Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix","volume":"81","author":"Huang","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0175","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3802\/jgo.2010.21.1.18","article-title":"Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy","volume":"21","author":"Lee","year":"2010","journal-title":"J Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib0180","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s10147-012-0457-x","article-title":"Long-term results and prognostic factors in patients with stage III-IVA squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy from a single institution study","volume":"18","author":"Kudaka","year":"2013","journal-title":"Int J Clin Oncol"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib0185","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/cam4.779","article-title":"Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer","volume":"5","author":"Li","year":"2016","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib0190","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1007\/s13277-015-3074-2","article-title":"Neoadjuvant chemotherapy followed by radical surgery as an alternative treatment to concurrent chemoradiotherapy for young premenopausal patients with FIGO stage IIB squamous cervical carcinoma","volume":"36","author":"Yang","year":"2015","journal-title":"Tumor Biol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0195","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s13277-015-3914-0","article-title":"The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease","volume":"37","author":"Kotowicz","year":"2016","journal-title":"Tumour Biol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib0200","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.3892\/ol.2015.3015","article-title":"Tumor size and lymph node status determined by imaging are reliable factors for predicting advanced cervical cancer prognosis","volume":"9","author":"Kyung","year":"2015","journal-title":"Oncol Lett"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib0205","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/0959-8049(92)90071-9","article-title":"Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma","volume":"28","author":"\u00c5vall-Lundqvist","year":"1992","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1999.5665","article-title":"Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix","volume":"76","author":"Juang","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0215","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3802\/jgo.2013.24.3.229","article-title":"Prognostic factors and treatment outcome after radiotherapy in cervical cancer patients with isolated para-aortic lymph node metastases","volume":"24","author":"Jang","year":"2013","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib0220","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cca.2013.07.003","article-title":"Prognostic value of combined serum biomarkers in predicting outcomes in cervical cancer patients","volume":"424","author":"Li","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0225","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10147-014-0702-6","article-title":"Analysis of prognostic factors for patients with bulky squamous cell carcinoma of the uterine cervix who underwent neoadjuvant chemotherapy followed by radical hysterectomy","volume":"20","author":"Takatori","year":"2015","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0230","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ygyno.2021.06.005","article-title":"Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group","volume":"162","author":"Benito","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0235","first-page":"781","article-title":"Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging","volume":"100","author":"Ohara","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0240","doi-asserted-by":"crossref","first-page":"e0122361","DOI":"10.1371\/journal.pone.0122361","article-title":"The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0245","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ygyno.2016.04.029","article-title":"Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: role in the early diagnosis of recurrence","volume":"142","author":"Salvatici","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0250","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0090-8258(89)90164-9","article-title":"Value of squamous cell carcinoma antigen levels in invasive cervical carcinoma","volume":"34","author":"Maiman","year":"1989","journal-title":"Gynecol Oncol"},{"issue":"1\u20132","key":"10.1016\/j.gofs.2025.07.005_bib0255","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000138979","article-title":"Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome","volume":"74","author":"Ferrandina","year":"2008","journal-title":"Oncology"},{"issue":"11","key":"10.1016\/j.gofs.2025.07.005_bib0260","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1447-0756.2012.01871.x","article-title":"Outcomes and prognostic factors of cervical cancer after concurrent chemoradiation","volume":"38","author":"Kim","year":"2012","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0265","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/IGC.0000000000000613","article-title":"The value of diffusion-weighted imaging in predicting the prognosis of stage IB-IIA cervical squamous cell carcinoma after radical hysterectomy","volume":"26","author":"Zhou","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib0270","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1007\/s00330-020-06909-3","article-title":"Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis","volume":"30","author":"Woo","year":"2020","journal-title":"Eur Radiol"},{"issue":"18","key":"10.1016\/j.gofs.2025.07.005_bib0275","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1016\/j.ejca.2012.06.022","article-title":"The value of 3.0Tesla diffusion-weighted MRI for pelvic nodal staging in patients with early stage cervical cancer","volume":"48","author":"Klerkx","year":"2012","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0280","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000456006","article-title":"A comprehensive comparison of CT, MRI, positron emission tomography or positron emission tomography\/CT, and diffusion weighted imaging-MRI for detecting the lymph nodes metastases in patients with cervical cancer: a meta-analysis based on 67 studies","volume":"82","author":"Liu","year":"2017","journal-title":"Gynecol Obstet Invest"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0285","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00330-019-06461-9","article-title":"Diagnostic performance of MR imaging in evaluating prognostic factors in patients with cervical cancer: a meta-analysis","volume":"30","author":"Xiao","year":"2020","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0290","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.mri.2013.12.007","article-title":"The value of diffusion-weighted MRI to evaluate the response to radiochemotherapy for cervical cancer","volume":"32","author":"Kuang","year":"2014","journal-title":"Magn Reson Imaging"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0295","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1148\/radiol.2017161299","article-title":"Value of dynamic contrast-enhanced and diffusion-weighted MR imaging in the detection of pathologic complete response in cervical cancer after neoadjuvant therapy: a retrospective observational study","volume":"284","author":"Jalaguier-Coudray","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.gofs.2025.07.005_bib0300","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mri.2020.06.014","article-title":"Prediction of early response to concurrent chemoradiotherapy in cervical cancer: value of multi-parameter MRI combined with clinical prognostic factors","volume":"72","author":"Zheng","year":"2020","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0305","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00330-018-5510-3","article-title":"Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: a multicentre study","volume":"29","author":"Thomeer","year":"2019","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib0310","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00330-017-5233-x","article-title":"The PRICE study: the role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery","volume":"28","author":"Valentini","year":"2018","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0315","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00330-018-5768-5","article-title":"Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery-the \u201cPRICE\u201d study 2: role of conventional and DW-MRI","volume":"29","author":"Gui","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.gofs.2025.07.005_bib0320","doi-asserted-by":"crossref","first-page":"100883","DOI":"10.1016\/j.gore.2021.100883","article-title":"Diffusion-weighted MRI to detect early response to chemoradiation in cervical cancer: a systematic review and meta-analysis","volume":"38","author":"Harry","year":"2021","journal-title":"Gynecol Oncol Rep"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0325","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/radiol.13121746","article-title":"Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy","volume":"269","author":"Lakhman","year":"2013","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib0330","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/0284185115620948","article-title":"Early stage cervical cancer: role of magnetic resonance imaging after conization in determining residual tumor","volume":"57","author":"Woo","year":"2016","journal-title":"Acta Radiol"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib0335","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.21873\/anticanres.13916","article-title":"The diagnostic accuracy and postoperative outcomes of cervical cancer patients for MR-invisible or MR-visible diagnosis of combined T2- and diffusion-weighted 3T MRI using the external phased-array receiver","volume":"39","author":"Roh","year":"2019","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib0340","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1007\/s00330-015-4156-7","article-title":"Prediction of disease progression following concurrent chemoradiotherapy for uterine cervical cancer: value of post-treatment diffusion-weighted imaging","volume":"26","author":"Park","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.gofs.2025.07.005_bib0345","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12885-016-2619-0","article-title":"Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation","volume":"16","author":"Marconi","year":"2016","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0350","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s00330-021-08279-w","article-title":"Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy","volume":"32","author":"Zhang","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.gofs.2025.07.005_bib0355","doi-asserted-by":"crossref","first-page":"109787","DOI":"10.1016\/j.ejrad.2021.109787","article-title":"Combined dynamic contrast enhanced MRI parameter with clinical factors predict the survival of concurrent chemo-radiotherapy in patients with 2018 FIGO IIICr stage cervical cancer","volume":"141","author":"Qin","year":"2021","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0360","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1148\/radiol.2015150400","article-title":"Association of apparent diffusion coefficient with disease recurrence in patients with locally advanced cervical cancer treated with radical chemotherapy and radiation therapy","volume":"279","author":"Gladwish","year":"2016","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib0365","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.1007\/s00330-020-07632-9","article-title":"Staging, recurrence and follow-up of uterine cervical cancer using MRI: updated guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018","volume":"31","author":"Manganaro","year":"2021","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0370","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ygyno.2022.03.006","article-title":"Prognostic impact of waiting time between diagnosis and treatment in patients with cervical cancer: a nationwide population-based study","volume":"165","author":"Hack","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib0375","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ijrobp.2017.03.045","article-title":"Adjuvant chemoradiation therapy for cervical cancer and effect of timing and duration on treatment outcome","volume":"98","author":"Jhawar","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0380","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3802\/jgo.2015.26.4.262","article-title":"Longer waiting times for early stage cervical cancer patients undergoing radical hysterectomy are associated with diminished long-term overall survival","volume":"26","author":"Nanthamongkolkul","year":"2015","journal-title":"J Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib0385","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/IGC.0000000000000211","article-title":"Effect of treatment delay on survival in patients with cervical cancer: a historical cohort study","volume":"24","author":"Perri","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0390","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00404-011-1966-y","article-title":"Prognostic factors in stage IA-IIA cervical cancer patients treated surgically: does the waiting time to the operation affect survival?","volume":"285","author":"Umezu","year":"2012","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0395","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2020.05.019","article-title":"Wait-time for hysterectomy and survival of women with early-stage cervical cancer: a clinical implication during the coronavirus pandemic","volume":"158","author":"Matsuo","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib0400","doi-asserted-by":"crossref","first-page":"e0221946","DOI":"10.1371\/journal.pone.0221946","article-title":"Effect of time interval from diagnosis to treatment for cervical cancer on survival: a nationwide cohort study","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0405","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4143\/crt.2021.023","article-title":"Effect of waiting time from pathological diagnosis to definitive concurrent chemoradiation for cervical cancer on overall survival","volume":"54","author":"Noh","year":"2022","journal-title":"Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0410","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2017.12.010","article-title":"Delays in definitive cervical cancer treatment: an analysis of disparities and overall survival impact","volume":"149","author":"Ramey","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"33","key":"10.1016\/j.gofs.2025.07.005_bib0415","doi-asserted-by":"crossref","first-page":"e4568","DOI":"10.1097\/MD.0000000000004568","article-title":"Factors involved in the delay of treatment initiation for cervical cancer patients: a nationwide population-based study","volume":"95","author":"Shen","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib0420","doi-asserted-by":"crossref","first-page":"e0220080","DOI":"10.1371\/journal.pone.0220080","article-title":"The diagnostic performance of PET\/CT scans for the detection of para-aortic metastatic lymph nodes in patients with cervical cancer: a meta-analysis","volume":"14","author":"Yu","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0425","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3857\/roj.2017.00206","article-title":"Value of imaging study in predicting pelvic lymph node metastases of uterine cervical cancer","volume":"35","author":"Jung","year":"2017","journal-title":"Radiat Oncol J"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0430","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2967\/jnumed.109.066217","article-title":"Diagnostic value of (18)F-FDG PET for evaluation of paraaortic nodal metastasis in patients with cervical carcinoma: a metaanalysis","volume":"51","author":"Kang","year":"2010","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0435","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00261-014-0194-x","article-title":"18F-FDG-PET\/CT is of limited value in primary staging of early stage cervical cancer","volume":"40","author":"Driscoll","year":"2015","journal-title":"Abdom Imaging"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib0440","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/MNM.0000000000000198","article-title":"Role of 18F-FDG PET\/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: comparison with MRI findings","volume":"35","author":"Lv","year":"2014","journal-title":"Nucl Med Commun"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0445","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0972-3919.106699","article-title":"Fluorodeoxyglucose positron emission tomography-computed tomography in evaluation of pelvic and para-aortic nodal involvement in early stage and operable cervical cancer: comparison with surgicopathological findings","volume":"26","author":"Bansal","year":"2011","journal-title":"Indian J Nucl Med"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0450","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jjco\/hyu161","article-title":"The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it","volume":"45","author":"Nogami","year":"2015","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0455","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.2005.03.5964","article-title":"Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy","volume":"24","author":"Chou","year":"2006","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib0460","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/IGC.0b013e31829ee012","article-title":"Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography or PET-computed tomography in cervical cancer: a meta-analysis","volume":"23","author":"Zhao","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib0465","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3390\/diagnostics11071258","article-title":"A systematic review and meta-analysis of the prognostic impact of pretreatment fluorodeoxyglucose positron emission tomography\/computed tomography parameters in patients with locally advanced cervical cancer treated with concomitant chemoradiotherapy","volume":"11","author":"Han","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0470","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/RLU.0000000000001049","article-title":"Prognostic implications of the SUVmax of primary tumors and metastatic lymph node measured by 18F-FDG PET in patients with uterine cervical cancer: a meta-analysis","volume":"41","author":"Sarker","year":"2016","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0475","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s13139-010-0062-8","article-title":"The prognostic value of the metabolic tumor volume in FIGO stage IA to IIB cervical cancer for tumor recurrence: measured by F-18 FDG PET\/CT","volume":"45","author":"Kim","year":"2011","journal-title":"Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib0480","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1245\/s10434-011-1583-9","article-title":"Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma","volume":"18","author":"Leblanc","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib0485","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/cncr.25739","article-title":"Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography\/computed tomography findings","volume":"117","author":"Ramirez","year":"2011","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib0490","first-page":"677","volume":"49","author":"Carr\u00e9","year":"2021","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0495","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jmig.2013.07.007","article-title":"Lymphadenectomy in locally advanced cervical cancer study (LiLACS): phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancer","volume":"21","author":"Frumovitz","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib0500","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1007\/s00259-019-04659-z","article-title":"Tumour and pelvic lymph node metabolic activity on FDG-PET\/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer","volume":"47","author":"Martinez","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0505","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/IGC.0b013e31827ef759","article-title":"Analysis of a continuous series of 34 young patients with early-stage cervical cancer selected for a vaginal radical trachelectomy: should \u201cstaging\u201d conization be systematically performed before this procedure?","volume":"23","author":"Uzan","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0510","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ygyno.2020.08.004","article-title":"Pathologic and clinical tumor size discordance in early-stage cervical cancer: does it matter?","volume":"159","author":"Vetter","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0515","doi-asserted-by":"crossref","first-page":"25992","DOI":"10.1038\/srep25992","article-title":"Accuracy of conization procedure for predicting pathological parameters of radical hysterectomy in stage Ia2-Ib1 (\u22642cm) cervical cancer","volume":"6","author":"Bai","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.02.017","article-title":"Cervical biopsy and excision procedure specimens lack sufficient predictive value for lymph-vascular space invasion seen at hysterectomy for cervical cancer","volume":"199","author":"Bidus","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2025.07.005_bib0525","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejogrb.2016.01.020","article-title":"Predictive factors for residual disease in hysterectomy specimens after conization in early-stage cervical cancer","volume":"199","author":"Wong","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0530","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/gyno.1994.1189","article-title":"A randomized prospective study comparing three techniques of conization: cold knife, laser, and LEEP","volume":"54","author":"Mathevet","year":"1994","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0535","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ygyno.2020.06.508","article-title":"Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: a multi-institutional study","volume":"159","author":"Casarin","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0540","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jmig.2020.04.015","article-title":"Preoperative conization and risk of recurrence in patients undergoing laparoscopic radical hysterectomy for early stage cervical cancer: a multicenter study","volume":"28","author":"Casarin","year":"2021","journal-title":"J Minim Invasive Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0545","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ygyno.2022.05.014","article-title":"Protective effect of pre-operative conization in patients undergoing surgical treatment for early-stage cervical cancer","volume":"166","author":"Gennari","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib0550","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1245\/s10434-021-09695-4","article-title":"Protective role of conization before radical hysterectomy in early-stage cervical cancer: a propensity-score matching study","volume":"28","author":"Bizzarri","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib0555","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1159\/000519646","article-title":"Preoperative conization may have a positive impact on survival in early-stage cervical cancer: a propensity-matched study","volume":"44","author":"Li","year":"2021","journal-title":"Oncol Res Treat"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0560","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00404-020-05798-7","article-title":"Does a pre-operative conization improve disease-free survival in early-stage cervical cancer?","volume":"303","author":"Benoit","year":"2021","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0565","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00404-021-06145-0","article-title":"Association of preoperative cone biopsy with recurrences after radical hysterectomy","volume":"305","author":"Klapdor","year":"2022","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0570","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ygyno.2021.12.023","article-title":"Cervical conization before primary radical hysterectomy has a protective effect on disease recurrence in early cervical cancer: a two-center matched cohort study according to surgical approach","volume":"164","author":"Kim","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib0575","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1200\/JCO.19.03012","article-title":"Recurrence rates in patients with cervical cancer treated with abdominal versus minimally invasive radical hysterectomy: a multi-institutional retrospective review study","volume":"38","author":"Uppal","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0580","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ijgo.13260","article-title":"Primary conization overcomes the risk of developing local recurrence following laparoscopic radical hysterectomy in early stage cervical cancer","volume":"151","author":"Bogani","year":"2020","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0585","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/ijgc-2021-002544","article-title":"SUCCOR cone study: conization before radical hysterectomy","volume":"32","author":"Chacon","year":"2022","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib0590","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1245\/s10434-022-11671-5","article-title":"SUCCOR risk: design and validation of a recurrence prediction index for early-stage cervical cancer","volume":"29","author":"Manzour","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0595","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/gyno.1996.0268","article-title":"Lymph node metastases and prognosis in patients with stage IA2 cervical cancer","volume":"63","author":"Buckley","year":"1996","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib0600","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/ijgc-2019-000849","article-title":"Prognostic significance of lymphovascular space invasion for stage IA1 and IA2 cervical cancer","volume":"30","author":"Margolis","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0605","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ygyno.2020.04.705","article-title":"Cervical cancer with\u22645mm depth of invasion and>7mm horizontal spread\u00a0\u2014\u00a0is lymph node assessment only required in patients with LVSI?","volume":"158","author":"Wenzel","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0610","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2022.02.017","article-title":"Prognostic value of the 2018 FIGO staging system for cervical cancer","volume":"165","author":"Mohamud","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0615","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3802\/jgo.2012.23.3.153","article-title":"Tumor volume and lymphovascular space invasion as a prognostic factor in early invasive adenocarcinoma of the cervix","volume":"23","author":"Murakami","year":"2012","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0620","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijgo.2015.03.042","article-title":"The potential for less radical surgery in women with stage IA2-IB1 cervical cancer","volume":"130","author":"Bai","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0625","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2007.04.010","article-title":"Preoperative lymph-vascular space invasion is associated with nodal metastases in women with early-stage cervical cancer","volume":"106","author":"Milam","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib0630","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2147\/CMAR.S292477","article-title":"Lymph-vascular space invasion in patients with stages IA2-IIA2 cervical cancer treated with laparoscopic versus open radical hysterectomy","volume":"13","author":"Zhao","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib0635","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4103\/jcrt.JCRT_467_17","article-title":"Preoperative predictors of pelvic and para-aortic lymph node metastases in cervical cancer","volume":"15","author":"Gulseren","year":"2019","journal-title":"J Can Res Ther"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0640","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2021.06.002","article-title":"The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients","volume":"162","author":"Ronsini","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"21","key":"10.1016\/j.gofs.2025.07.005_bib0645","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.3390\/cancers13215423","article-title":"Can conization specimens predict sentinel lymph node status in early-stage cervical cancer? A SENTICOL Group study","volume":"13","author":"Balaya","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0650","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/IGC.0000000000001236","article-title":"Incidence of lymph node metastases in women with low-risk early cervical cancer (<2cm) without lymph-vascular invasion","volume":"28","author":"Minig","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0655","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/ijgc-2019-000902","article-title":"Fusion imaging of ultrasound and MRI in the assessment of locally advanced cervical cancer: a prospective study","volume":"30","author":"Moro","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0660","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ygyno.2017.03.514","article-title":"Is parametrectomy always necessary in early-stage cervical cancer?","volume":"146","author":"Baiocchi","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0665","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12967-018-1531-6","article-title":"Identification of a low risk population for parametrial invasion in patients with early-stage cervical cancer","volume":"16","author":"Dabi","year":"2018","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0670","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ygyno.2016.11.029","article-title":"Less radical surgery for early-stage cervical cancer: can conization specimens help identify patients at low risk for parametrial involvement?","volume":"144","author":"Smith","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0675","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00404-017-4597-0","article-title":"Risk of parametrial invasion in women with early stage cervical cancer: a meta-analysis","volume":"297","author":"Ma","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib0680","doi-asserted-by":"crossref","first-page":"E2121","DOI":"10.3390\/jcm9072121","article-title":"Nomogram predicting the likelihood of parametrial involvement in early-stage cervical cancer: avoiding unjustified radical hysterectomies","volume":"9","author":"Benoit","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0685","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejso.2012.10.013","article-title":"Can parametrectomy be avoided in early cervical cancer? An algorithm for the identification of patients at low risk for parametrial involvement","volume":"39","author":"Gemer","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib0690","doi-asserted-by":"crossref","first-page":"759026","DOI":"10.3389\/fsurg.2021.759026","article-title":"Nomogram predicting parametrial involvement based on the radical hysterectomy specimens in the early-stage cervical cancer","volume":"8","author":"Li","year":"2021","journal-title":"Front Surg"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0695","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1245\/s10434-008-0185-7","article-title":"Prognostic impact of satellite-lymphovascular space involvement in early-stage cervical cancer","volume":"16","author":"Herr","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0700","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ygyno.2015.06.035","article-title":"Satellite lymphovascular space invasion: an independent risk factor in early stage cervical cancer","volume":"138","author":"Pol","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0705","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ygyno.2005.01.004","article-title":"Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study","volume":"97","author":"Marchiol\u00e8","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0710","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/IGC.0b013e31822fa8bb","article-title":"Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix","volume":"22","author":"Singh","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib0715","first-page":"775","article-title":"Treatment and outcome of stage I Al squamous carcinoma of the cervix: a clinicopathologic study of 346 cases","volume":"37","author":"Liang","year":"2016","journal-title":"Eur J Gynaecol Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib0720","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/annonc\/mdg412","article-title":"Prognostic value of lymphovascular space invasion determined with hematoxylin\u00a0\u2013\u00a0eosin staining in early stage cervical carcinoma: results of a multivariate analysis","volume":"14","author":"Morice","year":"2003","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0725","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2004.07.027","article-title":"A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?","volume":"95","author":"Rutledge","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0730","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000082522","article-title":"Clinicopathological features influencing pelvic lymph node metastasis and vaginal and parametrial involvement in patients with carcinoma of the cervix","volume":"59","author":"Silva-Filho","year":"2005","journal-title":"Gynecol Obstet Invest"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib0735","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1245\/s10434-008-0014-z","article-title":"Clinical value of immunohistochemically detected lymphovascular space invasion in early stage cervical carcinoma","volume":"15","author":"Lim","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib0740","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1136\/ijgc-2020-001274","article-title":"Prognostic value of lymphovascular space invasion in early-stage cervical cancer","volume":"30","author":"Weyl","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0745","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4274\/jtgga.galenos.2020.2020.0153","article-title":"Factors affecting parametrial involvement in cervical cancer patients with tumor size\u22644cm and selection of low-risk patient group","volume":"22","author":"Ak\u0131ll\u0131","year":"2021","journal-title":"J Turkish German Gynecol Assoc"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib0750","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/IGC.0000000000000688","article-title":"Significance of the factors associated with parametrial involvement in stage IB to IIA cervical cancer","volume":"26","author":"Xie","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0755","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5468\/ogs.2018.61.1.88","article-title":"Factors associated with parametrial involvement in patients with stage IB1 cervical cancer: who is suitable for less radical surgery?","volume":"61","author":"Lee","year":"2018","journal-title":"Obstet Gynecol Sci"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0760","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ygyno.2011.05.038","article-title":"Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery","volume":"122","author":"Kodama","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0765","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1525-1438.1998.09754.x","article-title":"Prognostic factors in surgically treated stage IB-IIB carcinoma of the cervix with negative lymph nodes","volume":"8","author":"Comerci","year":"1998","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2025.07.005_bib0770","doi-asserted-by":"crossref","first-page":"659313","DOI":"10.3389\/fonc.2021.659313","article-title":"Markers of prognosis for early stage cervical cancer patients (stage IB1, IB2) undergoing surgical treatment","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"},{"issue":"40","key":"10.1016\/j.gofs.2025.07.005_bib0775","doi-asserted-by":"crossref","first-page":"e17301","DOI":"10.1097\/MD.0000000000017301","article-title":"Prognostic value of lymphovascular space invasion in patients with early stage cervical cancer in Jilin, China: a retrospective study","volume":"98","author":"Yan","year":"2019","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib0780","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.3390\/cancers12123554","article-title":"Validation of the 2018 FIGO classification for cervical cancer: lymphovascular space invasion should be considered in IB1 stage","volume":"12","author":"Balaya","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0785","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.suronc.2018.05.015","article-title":"Surgical and oncological outcomes of an improved nerve-sparing radical hysterectomy technique: 6 years of experience at two centres","volume":"27","author":"Yin","year":"2018","journal-title":"Surg Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0790","doi-asserted-by":"crossref","DOI":"10.1177\/0300060519889741","article-title":"Prognostic factors affecting survival and recurrence in patients with early cervical squamous cell cancer following radical hysterectomy","volume":"48","author":"Li","year":"2020","journal-title":"J Int Med Res"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0795","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/ijgc-00009577-200403000-00015","article-title":"Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy","volume":"14","author":"Ayhan","year":"2004","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0800","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ygyno.2021.12.026","article-title":"Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: a systematic review and meta-analysis","volume":"164","author":"Thelissen","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"24","key":"10.1016\/j.gofs.2025.07.005_bib0805","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1200\/JCO.2012.47.3520","article-title":"Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging","volume":"31","author":"Gouy","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib0810","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ejso.2019.11.496","article-title":"Added value of para-aortic surgical staging compared to 18F-FDG PET\/CT on the external beam radiation field for patients with locally advanced cervical cancer: an ONCO-GF study","volume":"46","author":"De Cuypere","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0815","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12885-021-07821-9","article-title":"False negative rate at 18F-FDG PET\/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology","volume":"21","author":"Gouy","year":"2021","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib0820","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1634\/theoncologist.2011-0007","article-title":"Analysis of morbidity and clinical implications of laparoscopic para-aortic lymphadenectomy in a continuous series of 98 patients with advanced-stage cervical cancer and negative PET-CT imaging in the para-aortic area","volume":"16","author":"Uzan","year":"2011","journal-title":"Oncologist [Internet]"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib0825","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/ijgc-2020-001351","article-title":"How should we stage and tailor treatment strategy in locally advanced cervical cancer? Imaging versus para-aortic surgical staging","volume":"30","author":"Martinez","year":"2020","journal-title":"Int J Gynecol Cancer [Internet]"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib0830","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/cncr.23400","article-title":"Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group study","volume":"112","author":"Gold","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0835","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0090-8258(03)00064-7","article-title":"Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer","volume":"89","author":"Lai","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib0840","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1136\/ijgc-2020-001973","article-title":"Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study","volume":"30","author":"Marnitz","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2025.07.005_bib0845","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0850","first-page":"CD008285","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis","year":"2010","journal-title":"Cochrane database Syst Rev"},{"key":"10.1016\/j.gofs.2025.07.005_bib0855","doi-asserted-by":"crossref","first-page":"779372","DOI":"10.3389\/fsurg.2021.779372","article-title":"Surgical outcomes of transperitoneal para-aortic lymphadenectomy compared with extraperitoneal approach in gynecologic cancers: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2021","journal-title":"Front Surg"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0860","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jmig.2014.10.011","article-title":"Comparison between transperitoneal and extraperitoneal laparoscopic paraaortic lymphadenectomy in gynecologic malignancies","volume":"22","author":"Akladios","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"issue":"11","key":"10.1016\/j.gofs.2025.07.005_bib0865","first-page":"838","article-title":"Curage lombo-aortique et cancers gyn\u00e9cologiques pelviens\u00a0: c\u0153lioscopie r\u00e9troperiton\u00e9ale ou transp\u00e9riton\u00e9ale\u00a0?","volume":"49","author":"Salhi","year":"2021","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0870","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.bulcan.2016.01.009","article-title":"Contribution du score de propension pour comparer la lymphad\u00e9nectomie lombo-aortique par voies transp\u00e9riton\u00e9ale et r\u00e9trop\u00e9riton\u00e9ale mono- ou multitrocarts","volume":"103","author":"Naoura","year":"2016","journal-title":"Bull Cancer (Paris)"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0875","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1245\/s10434-015-4874-8","article-title":"Single-port extra- and transperitoneal approach for paraaortic lymphadenectomy in gynecologic cancers: a propensity-adjusted analysis","volume":"23","author":"Beytout","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib0880","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1245\/s10434-020-08471-0","article-title":"Lomboaortic lymphadenectomy in gynecological oncology: laparotomy, laparoscopy or robot-assisted laparoscopy?","volume":"27","author":"Kerbage","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib0885","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.21873\/anticanres.12773","article-title":"Transperitoneal versus extraperitoneal laparoscopic lymphadenectomy for gynecological malignancies: a systematic review and meta-analysis","volume":"38","author":"Prodromidou","year":"2018","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib0890","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.ejso.2021.04.036","article-title":"Transperitoneal versus extraperitoneal laparoscopic aortic lymph nodal staging for locally advanced cervical cancer: a systematic review and meta-analysis","volume":"47","author":"Capozzi","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib0895","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10585-016-9817-7","article-title":"Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy","volume":"33","author":"Chargari","year":"2016","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.gofs.2025.07.005_bib0900","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejogrb.2019.02.033","article-title":"Para-aortic plus pelvic lymphadenectomy in locally advanced cervical cancer: a single institutional experience","volume":"236","author":"Mezquita","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0905","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jmig.2021.06.027","article-title":"Laparoscopic debulking of enlarged pelvic nodes during surgical para-aortic staging in locally advanced cervical cancer: a retrospective comparative cohort study","volume":"29","author":"D\u00edaz-Feijoo","year":"2022","journal-title":"J Minim Invasive Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0910","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2006.12.012","article-title":"Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma","volume":"105","author":"Leblanc","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0915","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/IGC.0b013e31823c241b","article-title":"Laparoscopic extraperitoneal para-aortic lymphadenectomy in the staging of locally advanced cervical cancer: is it a feasible procedure at a peripheral center?","volume":"22","author":"Benito","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib0920","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/IGC.0000000000000588","article-title":"Should systematic infrarenal para-aortic dissection be the rule in the pretherapeutic staging of primary or recurrent locally advanced cervix cancer patients with a negative preoperative para-aortic PET imaging?","volume":"26","author":"Leblanc","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib0925","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/S1470-2045(12)70011-6","article-title":"Nodal-staging surgery for locally advanced cervical cancer in the era of PET","volume":"13","author":"Gouy","year":"2012","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib0930","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/cncr.25408","article-title":"Therapeutic role of lymphadenectomy for cervical cancer","volume":"117","author":"Shah","year":"2011","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib0935","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/jso.21330","article-title":"Lymphadenectomy for patients with cervical cancer: is it of value?","volume":"100","author":"Rossi","year":"2009","journal-title":"J Surg Oncol"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib0940","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/IGC.0000000000000000","article-title":"Laparoscopic lymphadenectomy in advanced cervical cancer: prognostic and therapeutic value","volume":"23","author":"del\u00a0Pino","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib0945","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/jjco\/hyaa091","article-title":"Significance of para-aortic lymph node evaluation in patients with FIGO IIIC1 cervical cancer","volume":"50","author":"Cho","year":"2020","journal-title":"Jpn J Clin Oncol"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib0950","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1245\/s10434-013-3067-6","article-title":"The role of lymphadenectomy in cervical cancer patients: the significance of the number and the status of lymph nodes removed in 526 cases treated in a single institution","volume":"20","author":"Ditto","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0955","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ygyno.2009.03.009","article-title":"A case matched analysis of robotic radical hysterectomy with lymphadenectomy compared with laparoscopy and laparotomy","volume":"113","author":"Estape","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib0960","first-page":"804","article-title":"Laparoscopy versus laparotomy for pelvic and lombo-aortic lymphadenectomy. A 11-year experience","volume":"109","author":"Socolov","year":"2005","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0965","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0090-8258(89)90513-1","article-title":"Extraperitoneal versus transperitoneal selective paraaortic lymphadenectomy in the pretreatment surgical staging of advanced cervical carcinoma (a Gynecologic Oncology Group study)","volume":"33","author":"Weiser","year":"1989","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0970","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.gyobfe.2012.01.001","article-title":"Curage lombo-aortique dans le cancer du col de l\u2019ut\u00e9rus avanc\u00e9\u00a0: morbidit\u00e9 et impact sur les d\u00e9lais de prise en charge","volume":"40","author":"Souadka","year":"2012","journal-title":"Gynecol Obstet Fertil"},{"issue":"11","key":"10.1016\/j.gofs.2025.07.005_bib0975","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2241::AID-CNCR20>3.0.CO;2-T","article-title":"Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking","volume":"82","author":"Cosin","year":"1998","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib0980","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/ijgc-2022-003357","article-title":"Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking","volume":"32","author":"Olthof","year":"2022","journal-title":"Int J Gynecol Cancer"},{"issue":"14","key":"10.1016\/j.gofs.2025.07.005_bib0985","doi-asserted-by":"crossref","first-page":"e0331","DOI":"10.1097\/MD.0000000000010331","article-title":"Individualized pelvic lymphadenectomy should follow neoadjuvant concurrent chemoradiotherapy for locally advanced cervical cancer","volume":"97","author":"Wei","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib0990","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ygyno.2020.03.027","article-title":"FIGO 2018 staging criteria for cervical cancer: impact on stage migration and survival","volume":"157","author":"Grigsby","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib0995","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/1471-0528.14492","article-title":"Survival effect of laparoscopic para-aortic staging in locally advanced cervical cancer: a retrospective cohort analysis","volume":"124","author":"Pomel","year":"2017","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.05.026","article-title":"Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer: results of a prospective randomized trial","volume":"213","author":"K\u00f6hler","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib1005","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.3802\/jgo.2020.31.e79","article-title":"Surgical or imaging lymph node assessment in locally advanced cervical cancer: a systematic review and meta-analysis","volume":"31","author":"Delara","year":"2020","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ygyno.2017.09.012","article-title":"Pretherapeutic staging of locally advanced cervical cancer: inframesenteric paraaortic lymphadenectomy accuracy to detect paraaortic metastases in comparison with infrarenal paraaortic lymphadenectomy","volume":"147","author":"Aza\u00efs","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/IGC.0000000000000921","article-title":"Morbidity of staging inframesenteric paraaortic lymphadenectomy in locally advanced cervical cancer compared with infrarenal lymphadenectomy","volume":"27","author":"Petitnicolas","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1020","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ygyno.2012.02.008","article-title":"Location of aortic node metastases in locally advanced cervical cancer","volume":"125","author":"Gil-Moreno","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2020.05.004","article-title":"Implications of extraperitoneal paraaortic lymphadenectomy to the left renal vein in locally advanced cervical cancer. A Spanish multicenter study","volume":"158","author":"D\u00edaz-Feijoo","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.gofs.2025.07.005_bib1030","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3390\/jcm8111822","article-title":"Significance of malignant peritoneal cytology on the survival of women with early-stage cervical cancer: a Japanese Gynecologic Oncology Group study","volume":"8","author":"Matsuo","year":"2019","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib1035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/bjc.2015.266","article-title":"The impact of positive peritoneal cytology on prognosis in patients with cervical cancer: a meta-analysis","volume":"113","author":"Yoon","year":"2015","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib1040","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/dc.23296","article-title":"Peritoneal cytology as prognostic factor in cervical cancer","volume":"43","author":"Ditto","year":"2015","journal-title":"Diagn Cytopathol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3802\/jgo.2014.25.2.90","article-title":"The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I\/II uterine cervical cancer","volume":"25","author":"Kuji","year":"2014","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000382068","article-title":"The relationship between positive peritoneal cytology and the prognosis of patients with uterine cervical cancer","volume":"59","author":"Kurita","year":"2015","journal-title":"Acta Cytol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1055","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ygyno.2012.12.033","article-title":"Quality of life in long-term cervical cancer survivors: a population-based study","volume":"129","author":"Le Borgne","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1060","first-page":"223","article-title":"Radical pelvic surgery versus radical surgery plus radiotherapy for stage Ib carcinoma of the cervix uteri. Preliminary results of a prospective randomized clinical study","volume":"52","author":"Bilek","year":"1982","journal-title":"Arch Geschwulstforsch"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","article-title":"A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study","volume":"65","author":"Rotman","year":"2006","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1070","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.0004-8666.2003.00040.x","article-title":"Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer","volume":"43","author":"Ryan","year":"2003","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"16","key":"10.1016\/j.gofs.2025.07.005_bib1075","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1016\/j.ejca.2012.05.011","article-title":"Quality of life characteristics inpatients with cervical cancer","volume":"48","author":"Bjelic-Radisic","year":"2012","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib1080","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1002\/cncr.23094","article-title":"Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population","volume":"110","author":"Park","year":"2007","journal-title":"Cancer"},{"issue":"9077","key":"10.1016\/j.gofs.2025.07.005_bib1085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","article-title":"Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer","volume":"350","author":"Landoni","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0090-8258(89)90627-6","article-title":"Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer","volume":"32","author":"Barter","year":"1989","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib1095","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/1097-0142(19820315)49:6<1278::AID-CNCR2820490634>3.0.CO;2-R","article-title":"Results of radiation therapy given after radical hysterectomy","volume":"49","author":"Hogan","year":"1982","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.gofs.2025.07.005_bib1100","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/1097-0142(19890601)63:11<2220::AID-CNCR2820631127>3.0.CO;2-M","article-title":"Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage 1B cervical cancer","volume":"63","author":"Rettenmaier","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.gofs.2025.07.005_bib1105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejca.2020.10.037","article-title":"Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study","volume":"143","author":"Cibula","year":"2021","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1110","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2011.11.037","article-title":"Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer","volume":"124","author":"Cibula","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2007.12.002","article-title":"Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy","volume":"109","author":"Richard","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib1120","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/IGC.0000000000000974","article-title":"Completing or abandoning radical hysterectomy in early-stage lymph node\u00a0\u2013\u00a0positive cervical cancer: impact on disease-free survival and treatment-related toxicity","volume":"27","author":"Derks","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.gofs.2025.07.005_bib1125","first-page":"S35","article-title":"Outcomes of complete radical hysterectomy in early-stage cervical cancer patients with intra-operative detection of nodal metastases","volume":"96","author":"Tuipae","year":"2013","journal-title":"J Med Assoc Thail Chotmaihet Thangphaet"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1130","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/IGC.0b013e31823c369b","article-title":"The prognostic significance of multiple pelvic node metastases in cervical cancer patients treated with radical hysterectomy plus adjuvant chemoradiotherapy","volume":"22","author":"Okazawa","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2012.03.046","article-title":"Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapy","volume":"126","author":"Ziebarth","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1140","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0090-8258(90)90312-9","article-title":"Early invasive cervical cancer with pelvic lymph node involvement: to complete or not to complete radical hysterectomy?","volume":"37","author":"Potter","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1145","first-page":"498","article-title":"Outcomes of abandoned radical hysterectomy in patients with stages IB-IIA cervical cancer found to have positive nodes during the operation","volume":"15","author":"Suprasert","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2025.07.005_bib1150","doi-asserted-by":"crossref","first-page":"743794","DOI":"10.1155\/2010\/743794","article-title":"The abandoned radical hysterectomy for cervical cancer: clinical predictors and outcomes","volume":"2010","author":"Gray","year":"2010","journal-title":"Obstet Gynecol Int"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0028-2243(92)90045-Z","article-title":"Early stage cervical cancer: aborted versus completed radical hysterectomy","volume":"47","author":"Bremer","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib1160","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/IGC.0000000000001216","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology Guidelines for the management of patients with cervical cancer","volume":"28","author":"Cibula","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"S2","key":"10.1016\/j.gofs.2025.07.005_bib1165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ygyno.2005.04.016","article-title":"Study of lymphatic mapping and sentinel node identification in early stage cervical cancer","volume":"98","author":"Rob","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ygyno.2011.04.002","article-title":"Value of sentinel node mapping in cancer of the cervix","volume":"122","author":"Roy","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1471-0528.2011.03134.x","article-title":"Sentinel lymph node mapping in cervical cancer: the future?","volume":"119","author":"Eiriksson","year":"2012","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"13","key":"10.1016\/j.gofs.2025.07.005_bib1185","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1200\/JCO.2010.32.0432","article-title":"Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study","volume":"29","author":"L\u00e9curu","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1190","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ygyno.2010.01.035","article-title":"The sentinel node concept in early cervical cancer performs well in tumors smaller than 2cm","volume":"117","author":"Darlin","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib1195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fsurg.2020.00031","article-title":"Does the sentinel lymph node sampling alone improve quality of life in early cervical cancer management?","volume":"7","author":"Gianoni","year":"2020","journal-title":"Front Surg"},{"key":"10.1016\/j.gofs.2025.07.005_bib1200","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejca.2021.02.009","article-title":"Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: results of a multicentre randomised trial (SENTICOL-2)","volume":"148","author":"Mathevet","year":"2021","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib1205","doi-asserted-by":"crossref","first-page":"660","DOI":"10.6004\/jnccn.2020.0027","article-title":"NCCN guidelines insights: cervical cancer, version 1.2020: featured updates to the NCCN guidelines","volume":"18","author":"Abu-Rustum","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib1210","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1245\/s10434-020-09328-2","article-title":"Histopathologic validation of the sentinel node technique for early-stage cervical cancer patients","volume":"28","author":"Mathevet","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib1215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2020.06.034","article-title":"Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: the SENTIX trial","volume":"137","author":"Cibula","year":"2020","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1220","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/gyno.2000.5999","article-title":"Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer","volume":"79","author":"Dargent","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1225","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/gyno.2000.6041","article-title":"Sentinel lymph node detection in patients with cervical cancer","volume":"80","author":"Malur","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1230","first-page":"135","article-title":"Sentinel node detection in cervical cancer","volume":"96","author":"Verheijen","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1235","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1200\/JCO.2002.20.3.688","article-title":"Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy","volume":"20","author":"Levenback","year":"2002","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1240","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0090-8258(03)00059-3","article-title":"Laparoscopic identification of sentinel lymph nodes in early stage cervical cancer: prospective study using a combination of patent blue dye injection and technetium radiocolloid injection","volume":"89","author":"Lambaudie","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1245","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2006.11.021","article-title":"Sentinel lymph node biopsy improves staging in early cervical cancer","volume":"105","author":"Bats","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1250","first-page":"294","article-title":"Long-standing complications after treatment for cancer of the uterine cervix\u00a0\u2013\u00a0clinical significance of medical examination at 5 years after treatment","volume":"16","author":"Matsuura","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib1255","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jso.1158","article-title":"Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer","volume":"78","author":"Franchi","year":"2001","journal-title":"J Surg Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib1260","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/IGC.0b013e318263f06a","article-title":"Prospective study of sentinel lymph node biopsy without further pelvic lymphadenectomy in patients with sentinel lymph node-negative cervical cancer","volume":"22","author":"Niikura","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib1265","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.eururo.2006.08.015","article-title":"Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer","volume":"50","author":"Briganti","year":"2006","journal-title":"Eur Urol"},{"issue":"2\u00a0Pt\u00a01","key":"10.1016\/j.gofs.2025.07.005_bib1270","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/AOG.0000000000000372","article-title":"Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life","volume":"124","author":"Yost","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1275","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ygyno.2014.03.003","article-title":"Quality of life of women with lower limb swelling or lymphedema 3\u20135 years following endometrial cancer","volume":"133","author":"Rowlands","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1280","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.juro.2007.10.072","article-title":"Complications of pelvic lymphadenectomy in 1380 patients undergoing radical retropubic prostatectomy between 1993 and 2006","volume":"179","author":"Musch","year":"2008","journal-title":"J Urol"},{"issue":"17","key":"10.1016\/j.gofs.2025.07.005_bib1285","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1158\/1078-0432.CCR-08-0346","article-title":"Molecular diagnosis of sentinel lymph node metastases in cervical cancer using squamous cell carcinoma antigen","volume":"14","author":"Yuan","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1290","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijgo.2015.08.019","article-title":"Lymph node micrometastases in initial stage cervical cancer and tumoral recurrence","volume":"133","author":"Colturato","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"issue":"9249","key":"10.1016\/j.gofs.2025.07.005_bib1295","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0140-6736(00)03566-2","article-title":"Molecular quantification and mapping of lymph-node micrometastases in cervical cancer","volume":"357","author":"Van Trappen","year":"2001","journal-title":"Lancet"},{"year":"2025","series-title":"Sentinel lymph node biopsy versus pelvic lymphadenectomy in cervical cancer: the PHENIX-I trial [oral communication]","author":"Ji-Hong","key":"10.1016\/j.gofs.2025.07.005_bib1300"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib1305","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00259-014-2732-8","article-title":"The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers","volume":"41","author":"Giammarile","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1310","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ygyno.2019.04.008","article-title":"Predictive factors of unexpected lymphatic drainage pathways in early-stage cervical cancer","volume":"154","author":"Balaya","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"20","key":"10.1016\/j.gofs.2025.07.005_bib1315","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","article-title":"Minimally invasive versus abdominal radical hysterectomy for cervical cancer","volume":"379","author":"Ramirez","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1320","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ygyno.2003.08.024","article-title":"Laparoscopic sentinel node mapping in early-stage cervical cancer","volume":"91","author":"Plante","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1325","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ygyno.2019.10.027","article-title":"Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancer","volume":"156","author":"Balaya","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1330","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2009.04.027","article-title":"Anaphylactic shock during the sentinel lymph node procedure for cervical cancer","volume":"114","author":"Bricou","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1335","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2015.09.076","article-title":"The sentinel node procedure in early stage cervical cancer, taking the next step; a diagnostic review","volume":"139","author":"Tax","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.gofs.2025.07.005_bib1340","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1245\/s10434-016-5236-x","article-title":"Sentinel node mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes-a meta-analysis","volume":"23","author":"Ruscito","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"3\u00a0Suppl.\u00a02","key":"10.1016\/j.gofs.2025.07.005_bib1345","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.ygyno.2008.03.012","article-title":"Lymphatic mapping and sentinel lymph node detection in women with cervical cancer","volume":"110","author":"Frumovitz","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib1350","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S1470-2045(18)30448-0","article-title":"Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial","volume":"19","author":"Frumovitz","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1355","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ygyno.2017.02.005","article-title":"Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer","volume":"145","author":"Salvo","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib1360","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jmig.2017.05.011","article-title":"Indocyanine green versus radiotracer with or without blue dye for sentinel lymph node mapping in stage>IB1 cervical cancer (>2\u00a0cm)","volume":"24","author":"Di Martino","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.gofs.2025.07.005_bib1365","first-page":"8394049","article-title":"Clinical study of sentinel lymph node detection to evaluate pelvic lymph node metastasis to determine the prognosis of patients with early cervical cancer","volume":"2022","author":"Li","year":"2022","journal-title":"Appl Bionics Biomech"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1370","first-page":"e1401","article-title":"Indocyanine green versus technetium-99m with blue dye for sentinel lymph node detection in early-stage cervical cancer: a systematic review and meta-analysis","volume":"5","author":"Baeten","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib1375","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1177\/0300060518803041","article-title":"Indocyanine green can stand alone in detecting sentinel lymph nodes in cervical cancer","volume":"46","author":"Ulain","year":"2018","journal-title":"J Int Med Res"},{"issue":"34","key":"10.1016\/j.gofs.2025.07.005_bib1380","doi-asserted-by":"crossref","first-page":"e27035","DOI":"10.1097\/MD.0000000000027035","article-title":"Sentinel lymph node mapping in early-stage cervical cancer: meta-analysis","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejso.2014.09.010","article-title":"Sentinel node biopsy for lymph nodal staging of uterine cervix cancer: a systematic review and meta-analysis of the pertinent literature","volume":"41","author":"Kadkhodayan","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1390","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.3802\/jgo.2017.28.e13","article-title":"The detection of sentinel lymph nodes in laparoscopic surgery for uterine cervical cancer using 99m-technetium-tin colloid, indocyanine green, and blue dye","volume":"28","author":"Tanaka","year":"2017","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1395","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ygyno.2019.11.026","article-title":"Combining indocyanine green and Tc99-nanocolloid does not increase the detection rate of sentinel lymph nodes in early stage cervical cancer compared to Indocyanine Green alone","volume":"156","author":"L\u00fchrs","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1400","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2015.01.548","article-title":"Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A)","volume":"137","author":"Kato","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1405","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2006.01.027","article-title":"Early cervical cancer and parametrial involvement: is it significant?","volume":"103","author":"Steed","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1410","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/gyno.2001.6493","article-title":"How important is removal of the parametrium at surgery for carcinoma of the cervix?","volume":"84","author":"Covens","year":"2002","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib1415","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/cncr.22899","article-title":"Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy","volume":"110","author":"Wright","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1420","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/AOG.0b013e3181ab474d","article-title":"Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer","volume":"114","author":"Frumovitz","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1425","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2008.02.004","article-title":"A prospective study of sentinel lymph node status and parametrial involvement in patients with small tumour volume cervical cancer","volume":"109","author":"Strnad","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1430","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ygyno.2018.04.571","article-title":"Less versus more radical surgery in stage IB1 cervical cancer: a population-based study of long-term survival","volume":"150","author":"Tseng","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib1435","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ajog.2020.11.041","article-title":"Less radical surgery for early-stage cervical cancer: a systematic review","volume":"224","author":"Wu","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib1440","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/ijgc-2021-002921","article-title":"ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer","volume":"31","author":"Schmeler","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1445","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2009.02.005","article-title":"Less radical surgery than radical hysterectomy in early stage cervical cancer: a pilot study","volume":"113","author":"Pluta","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib1450","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3389\/fonc.2018.00568","article-title":"Piver type II vs. type III hysterectomy in the treatment of early-stage cervical cancer: midterm follow-up results of a randomized controlled trial","volume":"8","author":"Sun","year":"2018","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib1455","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa2308900","article-title":"Simple versus radical hysterectomy in women with low-risk cervical cancer","volume":"390","author":"Plante","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1460","first-page":"265","article-title":"Five classes of extended hysterectomy for women with cervical cancer","volume":"44","author":"Piver","year":"1974","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1465","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejso.2011.12.017","article-title":"Class I versus class III radical hysterectomy in stage IB1-IIA cervical cancer. A prospective randomized study","volume":"38","author":"Landoni","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1470","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0090-8258(92)90108-U","article-title":"Proposal of a modified (FIGO 1985) classification of stages I and II cancer of the uterine cervix","volume":"47","author":"Ilijas","year":"1992","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1475","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.2000.6010","article-title":"Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study","volume":"80","author":"Landoni","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib1480","doi-asserted-by":"crossref","first-page":"408","DOI":"10.12659\/MSM.897291","article-title":"Is ovarian preservation feasible in early-stage adenocarcinoma of the cervix?","volume":"22","author":"Lu","year":"2016","journal-title":"Med Sci Monit"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1485","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1245\/s10434-012-2632-8","article-title":"Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis","volume":"20","author":"Hu","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1490","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1006\/gyno.2001.6277","article-title":"A study of risk factors for ovarian metastases in stage Ib-IIIb cervical carcinoma and analysis of ovarian function after a transposition","volume":"82","author":"Yamamoto","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1495","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1006\/gyno.2001.6316","article-title":"A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix","volume":"82","author":"Nakanishi","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib1500","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1097\/IGC.0000000000000780","article-title":"The safety of ovarian preservation in early-stage adenocarcinoma compared with squamous cell carcinoma of uterine cervix: a systematic review and meta-analysis of observational studies","volume":"26","author":"Jiao","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1505","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s10147-017-1225-8","article-title":"A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer","volume":"23","author":"Xie","year":"2018","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1510","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0000000000001754","article-title":"Ovarian conservation and overall survival in young women with early-stage cervical cancer","volume":"129","author":"Matsuo","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1515","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00404-018-4674-z","article-title":"Ovarian conservation is associated with better survival in young patients with T1N0M0 cervical adenocarcinoma: a population-based study","volume":"297","author":"Xu","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib1520","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/IGC.0000000000000231","article-title":"Ovarian preservation in young patients with stage I cervical adenocarcinoma: a surveillance, epidemiology, and end results study","volume":"24","author":"Lyu","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib1525","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.ejso.2021.04.009","article-title":"Risk of ovarian recurrence after ovarian conservation in early-stage cervical cancer treated with radical surgery: a propensity match analysis","volume":"47","author":"Bizzarri","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib1530","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.3802\/jgo.2017.28.e60","article-title":"Ovarian conservation for young women with clinical stage IB-IIB cervical cancer in Japan","volume":"28","author":"Matsuo","year":"2017","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib1535","doi-asserted-by":"crossref","first-page":"460.e1","DOI":"10.1016\/j.ajog.2016.04.023","article-title":"Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis","volume":"215","author":"Chen","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1540","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygyno.2014.12.011","article-title":"Should ovaries be removed or not in (early-stage) adenocarcinoma of the uterine cervix: a review","volume":"136","author":"Touhami","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"15","key":"10.1016\/j.gofs.2025.07.005_bib1545","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.3390\/cancers13153703","article-title":"Definitive chemoradiotherapy versus radical hysterectomy followed by tailored adjuvant therapy in women with early-stage cervical cancer presenting with pelvic lymph node metastasis on pretreatment evaluation: a propensity score matching analysis","volume":"13","author":"Park","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1550","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12885-020-6651-8","article-title":"Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gofs.2025.07.005_bib1555","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2147\/CMAR.S145926","article-title":"Comparison of survival outcomes between radical hysterectomy and definitive radiochemotherapy in stage IB1 and IIA1 cervical cancer","volume":"9","author":"Wu","year":"2017","journal-title":"Cancer Manag Res"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib1560","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5468\/ogs.2017.60.6.549","article-title":"A retrospective comparison of outcome in IB2 and IIA cervical cancer patients treated with primary concurrent chemoradiation versus radical hysterectomy with or without tailored adjuvant therapy","volume":"60","author":"Jang","year":"2017","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.gofs.2025.07.005_bib1565","first-page":"CD011478","article-title":"Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer","volume":"10","author":"Nama","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib1570","doi-asserted-by":"crossref","first-page":"e18738","DOI":"10.1097\/MD.0000000000018738","article-title":"Primary radical hysterectomy vs. chemoradiation for IB2-IIA cervical cancer: a systematic review and meta-analysis","volume":"99","author":"Yan","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"1\u00a0Pt\u00a01","key":"10.1016\/j.gofs.2025.07.005_bib1575","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jfma.2018.01.015","article-title":"Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery\u00b1neoadjuvant chemotherapy","volume":"118","author":"Hsieh","year":"2019","journal-title":"J Formos Med Assoc"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib1580","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1097\/IGC.0000000000000513","article-title":"Pathological risk factors and outcomes in women with stage IB2 cervical cancer treated with primary radical surgery versus chemoradiotherapy","volume":"25","author":"Bradbury","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1585","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.07.050","article-title":"Treatment patterns of FIGO stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy","volume":"111","author":"Zivanovic","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1590","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1525-1438.2007.00803.x","article-title":"Efficacy of different types of treatment in FIGO stage IB2 cervical cancer in Korea: results of a multicenter retrospective Korean study (KGOG-1005)","volume":"17","author":"Ryu","year":"2007","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.gofs.2025.07.005_bib1595","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijgo.13865","article-title":"Cancer of the cervix uteri: 2021 update","volume":"155","author":"Bhatla","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib1600","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/ijgc-2019-000323","article-title":"Minimally invasive radical hysterectomy: an analysis of oncologic outcomes from Hospital Italiano (Argentina)","volume":"29","author":"Odetto","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib1605","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/ijgc-2019-000994","article-title":"Comparison of laparoscopic and open radical hysterectomy in cervical cancer patients with tumor size\u22642cm","volume":"30","author":"Chen","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1610","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3802\/jgo.2021.32.e17","article-title":"Comparison between laparoscopic and abdominal radical hysterectomy for stage IB1 and tumor size<2cm cervical cancer with visible or invisible tumors: a multicentre retrospective study","volume":"32","author":"Li","year":"2021","journal-title":"J Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib1615","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/ijgc-2021-002505","article-title":"Oncologic outcomes of minimally invasive versus open radical hysterectomy for early stage cervical carcinoma and tumor size<2cm: a systematic review and meta-analysis","volume":"31","author":"Nasioudis","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib1620","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/ijgc-2020-002086","article-title":"Oncological outcomes of laparoscopic radical hysterectomy versus radical abdominal hysterectomy in patients with early-stage cervical cancer: a multicenter analysis","volume":"31","author":"Rodriguez","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2025.07.005_bib1625","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejca.2020.04.006","article-title":"Survival of patients with early-stage cervical cancer after abdominal or laparoscopic radical hysterectomy: a nationwide cohort study and literature review","volume":"133","author":"Wenzel","year":"2020","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib1630","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/ijgc-2020-001504","article-title":"Comparison of laparoscopic and abdominal radical hysterectomy for early stage cervical cancer: oncologic outcomes based on tumor diameter","volume":"30","author":"He","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1635","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ygyno.2019.06.023","article-title":"Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028)","volume":"154","author":"Paik","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1640","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/ijgc-2020-001506","article-title":"SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer","volume":"30","author":"Chiva","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1645","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ygyno.2019.12.038","article-title":"Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: survival outcomes","volume":"156","author":"Brandt","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"20","key":"10.1016\/j.gofs.2025.07.005_bib1650","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1804923","article-title":"Survival after minimally invasive radical hysterectomy for early-stage cervical cancer","volume":"379","author":"Melamed","year":"2018","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.gofs.2025.07.005_bib1655","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1200\/JCO.23.02335","article-title":"LACC trial: final analysis on overall survival comparing open versus minimally invasive radical hysterectomy for early-stage cervical cancer","volume":"42","author":"Ramirez","year":"2024","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib1660","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jmig.2020.12.012","article-title":"Comparison of survival outcomes after laparoscopic radical hysterectomy versus abdominal radical hysterectomy in patients with cervical cancer","volume":"28","author":"Hwang","year":"2021","journal-title":"J Minim Invasive Gynecol"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib1665","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jamaoncol.2020.1694","article-title":"Survival after minimally invasive vs. open radical hysterectomy for early-stage cervical cancer: a systematic review and meta-analysis","volume":"6","author":"Nitecki","year":"2020","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1670","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jmig.2020.12.023","article-title":"Minimally invasive radical hysterectomy for cervical cancer: a systematic review and meta-analysis","volume":"28","author":"Smith","year":"2021","journal-title":"J Minim Invasive Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1675","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00404-021-06348-5","article-title":"A meta-analysis of survival after minimally invasive radical hysterectomy versus abdominal radical hysterectomy in cervical cancer: center-associated factors matter","volume":"306","author":"Sun","year":"2022","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib1680","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jmig.2020.07.021","article-title":"Outcomes of minimally invasive versus open radical hysterectomy for early stage cervical cancer incorporating 2018 FIGO staging","volume":"28","author":"Levine","year":"2021","journal-title":"J Minim Invasive Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1685","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ygyno.2022.07.002","article-title":"The MEMORY study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: survival outcomes","volume":"166","author":"Leitao","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1690","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ijgo.13796","article-title":"Minimally invasive surgery and abdominal radical hysterectomy in patients with early-stage cervical cancer: a meta-analysis","volume":"57","author":"Yu","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.gofs.2025.07.005_bib1695","doi-asserted-by":"crossref","first-page":"762921","DOI":"10.3389\/fonc.2021.762921","article-title":"Comparison of minimally invasive versus abdominal radical hysterectomy for early-stage cervical cancer: an updated meta-analysis","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1700","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00404-021-06082-y","article-title":"Protective operative techniques in radical hysterectomy in early cervical carcinoma and their influence on disease-free and overall survival: a systematic review and meta-analysis of risk groups","volume":"304","author":"Kampers","year":"2021","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1705","doi-asserted-by":"crossref","first-page":"249.e1","DOI":"10.1016\/j.ajog.2019.09.036","article-title":"Incidence of adverse events in minimally invasive vs. open radical hysterectomy in early cervical cancer: results of a randomized controlled trial","volume":"222","author":"Obermair","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1710","doi-asserted-by":"crossref","first-page":"102046","DOI":"10.1016\/j.jogoh.2020.102046","article-title":"Comparison of survival outcomes between laparoscopic and abdominal radical hysterectomy for early-stage cervical cancer: a French multicentric study","volume":"50","author":"Zaccarini","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib1715","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1470-2045(20)30081-4","article-title":"Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial","volume":"21","author":"Frumovitz","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1720","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1477-7819-4-77","article-title":"Radiation-sparing managements for cervical cancer: a developing countries perspective","volume":"4","author":"Candelaria","year":"2006","journal-title":"World J Surg Oncol"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib1725","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/annonc\/mdg333","article-title":"A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation","volume":"14","author":"Due\u00f1as-Gonzalez","year":"2003","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1730","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0360-3016(02)02971-1","article-title":"Operable stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy","volume":"54","author":"Atlan","year":"2002","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib1735","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1748-717X-2-9","article-title":"Preoperative external beam radiotherapy and reduced dose brachytherapy for carcinoma of the cervix: survival and pathological response","volume":"2","author":"Jacinto","year":"2007","journal-title":"Radiat Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib1740","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0360-3016(89)90531-2","article-title":"Carcinoma of the uterine cervix stage III and early stage II. Prognostic value of the histological tumor regression after initial brachytherapy","volume":"17","author":"Calais","year":"1989","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1745","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0167-8140(92)90337-T","article-title":"Combined radiotherapy and surgery: local control and complications in early carcinoma of the uterine cervix\u00a0\u2014\u00a0the Villejuif experience, 1975\u20131984","volume":"23","author":"Gerbaulet","year":"1992","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib1750","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0360-3016(01)01602-9","article-title":"Combined brachytherapy and surgery for early carcinoma of the uterine cervix: analysis of extent of surgery on outcome","volume":"50","author":"Resbeut","year":"2001","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1755","first-page":"158","article-title":"Pathologic complete remission after preoperative intracavitary radiotherapy of cervical cancer stage Ib and IIa is a strong prognostic factor for long-term survival: analysis of the Radiumhemmet data 1989\u20131991","volume":"12","author":"Beskow","year":"2002","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1760","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.radonc.2009.05.004","article-title":"DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery","volume":"93","author":"Haie-Meder","year":"2009","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1765","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ygyno.2011.08.011","article-title":"Outcome in early cervical cancer following pre-operative low dose rate brachytherapy: a ten-year follow up of 257 patients treated at a single institution","volume":"123","author":"Ng\u00f4","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1770","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brachy.2012.04.007","article-title":"Interstitial preoperative high-dose-rate brachytherapy for early stage cervical cancer: dose\u2013volume histogram parameters, pathologic response and early clinical outcome","volume":"12","author":"Hannoun-Levi","year":"2013","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1775","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1245\/s10434-012-2630-x","article-title":"Laparoscopic radical hysterectomy after preoperative brachytherapy for stage IB1 cervical cancer: feasibility, results, and surgical implications in a large bicentric study of 162 consecutive cases","volume":"20","author":"Uzan","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1780","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.radonc.2016.07.003","article-title":"Preoperative image-guided brachytherapy in early stage cervical cancers","volume":"120","author":"Escande","year":"2016","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1785","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejso.2015.12.003","article-title":"Early stage cervical cancer: brachytherapy followed by type a hysterectomy versus type B radical hysterectomy alone, a retrospective evaluation","volume":"42","author":"Lacorre","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1790","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ygyno.2016.12.026","article-title":"Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: clinical results and prognostic factors","volume":"144","author":"Escande","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1795","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ygyno.2021.01.034","article-title":"The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer","volume":"161","author":"Varela Cagetti","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1800","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5114\/jcb.2022.112697","article-title":"Pre-operative high-dose-rate brachytherapy in early-stage cervical cancer: long-term single-center results","volume":"14","author":"Kellas-\u015al\u0119czka","year":"2022","journal-title":"J Contemp Brachytherapy"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib1805","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2014.07.017","article-title":"National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements","volume":"90","author":"Gill","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1810","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2013.05.033","article-title":"Trends in the utilization of brachytherapy in cervical cancer in the United States","volume":"87","author":"Han","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib1815","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ijrobp.2008.03.032","article-title":"Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy","volume":"71","author":"Georg","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib1820","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1825","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijrobp.2019.10.042","article-title":"A phase II trial of stereotactic ablative radiation therapy as a boost for locally advanced cervical cancer","volume":"106","author":"Albuquerque","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1830","first-page":"CD011000","article-title":"Palliative interventions for controlling vaginal bleeding in advanced cervical cancer","volume":"3","author":"Eleje","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib1835","first-page":"CD011000","article-title":"Palliative interventions for controlling vaginal bleeding in advanced cervical cancer","volume":"2015","author":"Eleje","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib1840","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.21037\/tcr-21-467","article-title":"Efficacy of preoperative brachytherapy for controlling vaginal bleeding in early-stage cervical cancer: a retrospective study","volume":"10","author":"Ping","year":"2021","journal-title":"Transl Cancer Res"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1845","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13014-022-01995-7","article-title":"Hypofractionated radiation leads to more rapid bleeding cessation in women with vaginal bleeding secondary to gynecologic malignancy","volume":"17","author":"Moradi","year":"2022","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1850","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2018.10.018","article-title":"Surgical treatment of \u201cintermediate risk\u201d lymph node negative cervical cancer patients without adjuvant radiotherapy\u00a0\u2013\u00a0a retrospective cohort study and review of the literature","volume":"151","author":"Cibula","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1855","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1860","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.3802\/jgo.2017.28.e34","article-title":"Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update","volume":"28","author":"Landoni","year":"2017","journal-title":"J Gynecol Oncol"},{"issue":"35","key":"10.1016\/j.gofs.2025.07.005_bib1865","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib1870","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.radonc.2021.01.005","article-title":"Results of image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study","volume":"157","author":"Petric","year":"2021","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib1875","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.gofs.2025.07.005_bib1880","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1200\/JCO.2017.75.9985","article-title":"Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial","volume":"36","author":"Gupta","year":"2018","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1885","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0090-8258(03)00173-2","article-title":"Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group","volume":"89","author":"Keys","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"15","key":"10.1016\/j.gofs.2025.07.005_bib1890","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.gofs.2025.07.005_bib1895","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib1900","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1470-2045(23)00147-X","article-title":"Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial","volume":"24","author":"Mileshkin","year":"2023","journal-title":"Lancet Oncol"},{"issue":"17","key":"10.1016\/j.gofs.2025.07.005_bib1905","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/S0959-8049(03)00425-8","article-title":"Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials","volume":"39","year":"2003","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib1910","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/bjc.2013.230","article-title":"A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer","volume":"108","author":"McCormack","year":"2013","journal-title":"Br J Cancer"},{"issue":"10462","key":"10.1016\/j.gofs.2025.07.005_bib1915","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(24)01438-7","article-title":"Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial","volume":"404","author":"McCormack","year":"2024","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib1920","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1136\/ijgc-2024-005572","article-title":"Are we making progress in curing advanced cervical cancer-again?","volume":"34","author":"Lindegaard","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib1925","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMoa2112187","article-title":"Survival with cemiplimab in recurrent cervical cancer","volume":"386","author":"Tewari","year":"2022","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.gofs.2025.07.005_bib1930","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib1935","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S1470-2045(23)00479-5","article-title":"Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial","volume":"24","author":"Monk","year":"2023","journal-title":"Lancet Oncol"},{"issue":"10460","key":"10.1016\/j.gofs.2025.07.005_bib1940","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(24)01808-7","volume":"404","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"issue":"10434","key":"10.1016\/j.gofs.2025.07.005_bib1945","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib1950","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1634\/theoncologist.2011-0276","article-title":"Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer","volume":"17","author":"Morice","year":"2012","journal-title":"Oncologist"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib1955","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s00066-017-1174-1","article-title":"Adjuvant hysterectomy after radiochemotherapy for locally advanced cervical cancer","volume":"193","author":"Hass","year":"2017","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1960","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ygyno.2019.12.001","article-title":"Lessons from radiochemotherapy and modern image-guided adaptive brachytherapy followed by hysterectomy","volume":"156","author":"Varela Cagetti","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1965","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.3802\/jgo.2019.30.e41","article-title":"Preoperative chemoradiation followed by hysterectomy for cervical cancer: patterns of care and survival in a large, hospital database","volume":"30","author":"Albert","year":"2019","journal-title":"J Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib1970","first-page":"3175","article-title":"Utilization of hysterectomy following chemoradiation for IB2\/IIA2 cervical cancer in the national cancer data base","volume":"38","author":"Haque","year":"2018","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib1975","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.radonc.2016.07.010","article-title":"Post-radiation hysterectomy in locally advanced cervical cancer: outcomes and dosimetric impact","volume":"120","author":"Mazeron","year":"2016","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib1980","first-page":"1661","article-title":"The role of completion surgery after concurrent radiochemotherapy in locally advanced stages IB2-IIB cervical cancer","volume":"33","author":"Chereau","year":"2013","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1985","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/IGC.0b013e3181c9e385","article-title":"Results of surgery after concurrent chemoradiotherapy in advanced cervical cancer: comparison of extended hysterectomy and extrafascial hysterectomy","volume":"20","author":"Motton","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib1990","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ijgc-00009577-200807000-00018","article-title":"Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma","volume":"18","author":"Darus","year":"2008","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib1995","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s10147-019-01551-6","article-title":"The role of additional hysterectomy after concurrent chemoradiation for patients with locally advanced cervical cancer","volume":"25","author":"Yoshida","year":"2020","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2000","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.18632\/oncotarget.23165","article-title":"Chemoradiotherapy in combination with radical surgery is associated with better outcome in cervical cancer patients","volume":"9","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gofs.2025.07.005_bib2005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijsu.2017.10.028","article-title":"Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: a population-based, propensity score-matched analysis","volume":"48","author":"Wu","year":"2017","journal-title":"Int J Surg"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijgo.2013.07.041","article-title":"Surgical morbidity and oncologic results after concurrent chemoradiation therapy for advanced cervical cancer","volume":"125","author":"Sun","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejogrb.2010.11.016","article-title":"Completion surgery or not after concurrent chemoradiotherapy for locally advanced cervical cancer?","volume":"155","author":"L\u00e8guevaque","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2020","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.3802\/jgo.2020.31.e16","article-title":"Completion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma: updated survival outcomes and experience in post-radiation surgery","volume":"31","author":"Yang","year":"2020","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib2025","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.3802\/jgo.2016.27.e40","article-title":"Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma","volume":"27","author":"Yang","year":"2016","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2030","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s12885-021-08146-3","article-title":"Clinical outcomes observation in stage IIB-IIIB cervical cancer treated by adjuvant surgery following concurrent chemoradiotherapy","volume":"21","author":"Li","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0040-1701459","article-title":"Is surgical treatment an option for locally advanced cervical cancer in the presence of central residual tumor after chemoradiotherapy?","volume":"42","author":"Topuz","year":"2020","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.gofs.2025.07.005_bib2040","first-page":"1","article-title":"Adjuvant hysterectomy in patients with residual disease after radiation for locally advanced cervical cancer: a prospective longitudinal study","volume":"5","author":"Pervin","year":"2019","journal-title":"J Glob Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib2045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1634\/theoncologist.2009-0295","article-title":"Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer","volume":"15","author":"Touboul","year":"2010","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib2050","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/IGC.0000000000000171","article-title":"Radical surgery in patients with residual disease after (chemo)radiation for cervical cancer","volume":"24","author":"Boers","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13014-021-01843-0","article-title":"Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery","volume":"16","author":"Miller","year":"2021","journal-title":"Radiat Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib2060","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1245\/s10434-020-09302-y","article-title":"Minimally invasive approaches in locally advanced cervical cancer patients undergoing radical surgery after chemoradiotherapy: a propensity score analysis","volume":"28","author":"Ferrandina","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2065","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2009.05.043","article-title":"Total laparoscopic radical hysterectomy for locally advanced cervical carcinoma (stages IIB, IIA and bulky stages IB) after concurrent chemoradiation therapy: surgical morbidity and oncological results","volume":"114","author":"Colombo","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"18, Suppl.","key":"10.1016\/j.gofs.2025.07.005_bib2070","first-page":"27","article-title":"Adjuvant chemotherapy following chemo-radiation as primary treatment for locally advanced cervical cancer compared to chemo-radiation alone: the randomized phase 3 OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274)","volume":"39","author":"Mileshkin","year":"2021","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.gofs.2025.07.005_bib2075","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1200\/JCO.2009.25.9663","article-title":"Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix","volume":"29","author":"Due\u00f1as-Gonz\u00e1lez","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib2080","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.3802\/jgo.2019.30.e82","article-title":"A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial","volume":"30","author":"Tangjitgamol","year":"2019","journal-title":"J Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib2085","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.31557\/APJCP.2021.22.9.2977","article-title":"Long-term outcomes and sites of failure in locally advanced, cervical cancer patients treated by concurren t chemoradiation with or without adjuvant chemotherapy: ACTLACC trial","volume":"22","author":"Tovanabutra","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.gofs.2025.07.005_bib2090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1073274821989307","article-title":"A multi-institutional retrospective analysis of oncologic outcomes for patients with locally advanced cervical cancer undergoing platinum-based adjuvant chemotherapy after concurrent chemoradiotherapy","volume":"28","author":"Wu","year":"2021","journal-title":"Cancer Control"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib2095","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/COC.0000000000000458","article-title":"The significance of para-aortic nodal size and the role of adjuvant systemic chemotherapy in cervical cancer: an institutional experience","volume":"41","author":"Manders","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2100","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3892\/ol.2011.516","article-title":"Adjuvant chemotherapy following concurrent chemoradiotherapy for uterine cervical cancer with lymphadenopathy","volume":"3","author":"Abe","year":"2012","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/ijgc-2018-000022","article-title":"Adjuvant carboplatin and paclitaxel after concurrent cisplatin and radiotherapy in patients with locally advanced cervical cancer","volume":"29","author":"Yavas","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2110","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.3802\/jgo.2017.28.e15","article-title":"Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB\/IVA cervical cancer patients","volume":"28","author":"Mabuchi","year":"2017","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib2115","first-page":"558","article-title":"Comparison of the curative effect and safety of consolidation chemotherapy after concurrent chemoradiotherapy with concurrent chemoradiotherapy alone for locally advanced cervical cancer","volume":"39","author":"Tu","year":"2018","journal-title":"Eur J Gynaecol Oncol"},{"issue":"12","key":"10.1016\/j.gofs.2025.07.005_bib2120","first-page":"CD010401","article-title":"Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer","volume":"2014","author":"Tangjitgamol","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gofs.2025.07.005_bib2125","doi-asserted-by":"crossref","first-page":"103638","DOI":"10.1016\/j.critrevonc.2022.103638","article-title":"A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer","volume":"172","author":"Horeweg","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2130","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/IGC.0000000000000884","article-title":"Survival after pelvic exenteration for cervical cancer: a national cancer database study","volume":"27","author":"Graves","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib2135","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/IGC.0b013e3182a80aec","article-title":"Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients","volume":"24","author":"Chiantera","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib2140","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3390\/cancers14092346","article-title":"Long-term survival, prognostic factors, and quality of life of patients undergoing pelvic exenteration for cervical cancer","volume":"14","author":"Stanca","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib2145","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMoa1309748","article-title":"Improved survival with bevacizumab in advanced cervical cancer","volume":"370","author":"Tewari","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib2150","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.3802\/jgo.2020.31.e58","article-title":"Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands","volume":"31","author":"Burg","year":"2020","journal-title":"J Gynecol Oncol"},{"issue":"10103","key":"10.1016\/j.gofs.2025.07.005_bib2155","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(17)31607-0","article-title":"Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)","volume":"390","author":"Tewari","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib2160","first-page":"1615","article-title":"Patterns of metastases in cervical cancer: a population-based study","volume":"13","author":"Zhou","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"issue":"19","key":"10.1016\/j.gofs.2025.07.005_bib2165","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1200\/JCO.2014.58.4391","article-title":"Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase III trial JCOG0505","volume":"33","author":"Kitagawa","year":"2015","journal-title":"JCO"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib2170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11912-015-0440-6","article-title":"Adenocarcinoma of the cervix: should we treat it differently?","volume":"17","author":"Williams","year":"2015","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2175","first-page":"CD013348","article-title":"Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer","volume":"3","author":"Chuai","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"22","key":"10.1016\/j.gofs.2025.07.005_bib2180","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2009.26.9571","article-title":"Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer","volume":"28","author":"Monk","year":"2010","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.gofs.2025.07.005_bib2185","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJM199804023381412","article-title":"Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470","volume":"338","author":"Kudelka","year":"1998","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.gofs.2025.07.005_bib2190","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1200\/JCO.19.01009","article-title":"Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer","volume":"37","author":"Tewari","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12885-021-07869-7","article-title":"Cisplatin plus paclitaxel chemotherapy with or without bevacizumab in postmenopausal women with previously untreated advanced cervical cancer: a retrospective study","volume":"21","author":"Chu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gofs.2025.07.005_bib2200","doi-asserted-by":"crossref","first-page":"e2100355","DOI":"10.1200\/GO.21.00355","article-title":"Cost effectiveness of bevacizumab plus chemotherapy for the treatment of advanced and metastatic cervical cancer in India-a model-based economic analysis","volume":"8","author":"Gupta","year":"2022","journal-title":"JCO Glob Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2014.11.003","article-title":"Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: is it cost-effective?","volume":"136","author":"Phippen","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2210","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ygyno.2015.02.027","article-title":"A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer","volume":"137","author":"Minion","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"36","key":"10.1016\/j.gofs.2025.07.005_bib2215","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1200\/JCO.2017.74.5471","article-title":"Safety and efficacy of pembrolizumab in advanced, programmed death ligand 1\u00a0\u2013\u00a0positive cervical cancer: results from the phase Ib KEYNOTE-028 trial","volume":"35","author":"Frenel","year":"2017","journal-title":"JCO"},{"issue":"17","key":"10.1016\/j.gofs.2025.07.005_bib2220","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.18.01265","article-title":"Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study","volume":"37","author":"Chung","year":"2019","journal-title":"JCO"},{"issue":"11","key":"10.1016\/j.gofs.2025.07.005_bib2225","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/cancers12113188","article-title":"Real-world experience of pembrolizumab monotherapy in patients with recurrent or persistent cervical cancer: a Korean multi-center retrospective study (KGOG1041)","volume":"12","author":"Choi","year":"2020","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.gofs.2025.07.005_bib2230","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.18632\/oncotarget.3455","article-title":"The biology and treatment of oligometastatic cancer","volume":"6","author":"Reyes","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib2235","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jtcvs.2003.10.011","article-title":"Pulmonary metastases from uterine malignancies: results of surgical resection in 133 patients","volume":"127","author":"Anraku","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2240","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0029-7844(94)00389-U","article-title":"The role of endocervical curettage at cervical conization for high-grade dysplasia","volume":"85","author":"Kobak","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"2\u00a0Pt\u00a01","key":"10.1016\/j.gofs.2025.07.005_bib2245","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0002-9378(99)70200-0","article-title":"Cold-knife conization versus conization by the loop electrosurgical excision procedure: a randomized, prospective study","volume":"180","author":"Duggan","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2250","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1525-1438.2007.00758.x","article-title":"Less radical fertility-sparing surgery than radical trachelectomy in early cervical cancer","volume":"17","author":"Rob","year":"2007","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2255","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ygyno.2012.04.004","article-title":"Simple extrafascial trachelectomy and pelvic bilateral lymphadenectomy in early stage cervical cancer","volume":"126","author":"Palaia","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib2260","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1471-0528.1997.tb10946.x","article-title":"Abdominal radical trachelectomy: a new surgical technique for the conservative management of cervical carcinoma","volume":"104","author":"Smith","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.gofs.2025.07.005_bib2265","first-page":"285","article-title":"La trach\u00e9lectomie \u00e9largie\u00a0: une alternative \u00e0 l\u2019hyst\u00e9rectomie radicale dans le traitement des cancers infiltrants d\u00e9velopp\u00e9s sur la face externe du col ut\u00e9rin","volume":"2","author":"Dargent","year":"1994","journal-title":"JOBGYN"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2270","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ygyno.2005.01.042","article-title":"Laparoscopic abdominal radical trachelectomy","volume":"97","author":"Cibula","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2275","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1074-3804(05)60244-7","article-title":"Laparoscopic radical trachelectomy for stage Ib1 cervical cancer","volume":"10","author":"Lee","year":"2003","journal-title":"J Am Assoc Gynecol Laparosc"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib2280","doi-asserted-by":"crossref","first-page":"102407","DOI":"10.1016\/j.jogoh.2022.102407","article-title":"Trach\u00e9lectomie\u00a0: comment faire en pratique\u00a0? Revue de la litt\u00e9rature par le groupe FRANCOGYN","volume":"51","author":"Lefebvre","year":"2022","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"28","key":"10.1016\/j.gofs.2025.07.005_bib2285","doi-asserted-by":"crossref","first-page":"46580","DOI":"10.18632\/oncotarget.16233","article-title":"Oncologic and obstetrical outcomes with fertility-sparing treatment of cervical cancer: a systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2290","first-page":"29","article-title":"Sexual and reproductive outcomes in early stage cervical cancer patients after excisional cone as a fertility-sparing surgery: an Italian experience","volume":"15","author":"Fanfani","year":"2014","journal-title":"J Reprod Infertil"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2295","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.pdpdt.2014.06.001","article-title":"Fertility preservation by photodynamic therapy combined with conization in young patients with early stage cervical cancer: a pilot study","volume":"11","author":"Choi","year":"2014","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2300","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/IGC.0000000000000034","article-title":"Cervical conization and sentinel lymph node mapping in the treatment of stage I cervical cancer: is less enough?","volume":"24","author":"Andikyan","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2305","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.fertnstert.2010.11.010","article-title":"Excisional cone as fertility-sparing treatment in early-stage cervical cancer","volume":"95","author":"Fagotti","year":"2011","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib2310","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1097\/IGC.0b013e3182262059","article-title":"Conservative therapy in microinvasive adenocarcinoma of the uterine cervix is justified: an analysis of 59 cases and a review of the literature","volume":"21","author":"Baalbergen","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib2315","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/IGC.0b013e3181e768b6","article-title":"Conservative treatment of stage IA1 adenocarcinoma of the uterine cervix with a long-term follow-up","volume":"20","author":"Yahata","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2320","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/IGC.0b013e3181a1a297","article-title":"Conization using electrosurgical conization and cold coagulation for international federation of gynecology and obstetrics stage IA1 squamous cell carcinomas of the uterine cervix","volume":"19","author":"Lee","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2325","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ygyno.2007.07.062","article-title":"Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature","volume":"107","author":"Bisseling","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2330","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0090-8258(03)00333-0","article-title":"Stage Ia1 cervical squamous cell carcinoma: conservative management after laser conization with positive margins","volume":"90","author":"Itsukaichi","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib2335","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0002-9378(97)70394-6","article-title":"Conservative conization for microinvasive carcinoma of the cervix","volume":"176","author":"Tseng","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2340","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/gyno.1993.1271","article-title":"Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix","volume":"51","author":"Morris","year":"1993","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2345","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ygyno.2021.07.031","article-title":"Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer: oncological outcomes","volume":"163","author":"Hruda","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib2350","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.fertnstert.2020.02.003","article-title":"Reproductive and oncologic outcomes after fertility-sparing surgery for early stage cervical cancer: a systematic review","volume":"113","author":"Nezhat","year":"2020","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2355","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ygyno.2019.04.007","article-title":"Long-term results of fertility-sparing treatment for early-stage cervical cancer","volume":"154","author":"Bogani","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"21","key":"10.1016\/j.gofs.2025.07.005_bib2360","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.3390\/jcm10214825","article-title":"Cervical cancer and fertility-sparing treatment","volume":"10","author":"Zaccarini","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2365","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/IGC.0000000000000023","article-title":"Fertility conserving management of early cervical cancer: our experience of LLETZ and pelvic lymph node dissection","volume":"24","author":"Lindsay","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2370","doi-asserted-by":"crossref","first-page":"e0189847","DOI":"10.1371\/journal.pone.0189847","article-title":"Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation","volume":"13","author":"Shim","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2375","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ygyno.2022.01.023","article-title":"Oncologic results of fertility sparing surgery of cervical cancer: an updated systematic review","volume":"165","author":"Morice","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib2380","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/ijgc-2020-001432","article-title":"Simple vaginal trachelectomy in women with early-stage low-risk cervical cancer who wish to preserve fertility: the new standard of care?","volume":"30","author":"Plante","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib2385","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/IGC.0000000000001319","article-title":"Long-term oncologic outcomes of uterine-preserving surgery in young women with stage Ib1 cervical cancer","volume":"28","author":"Tseng","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2390","doi-asserted-by":"crossref","first-page":"97.e1","DOI":"10.1016\/j.ajog.2021.08.029","article-title":"Open vs. minimally invasive radical trachelectomy in early-stage cervical cancer: International Radical Trachelectomy Assessment Study","volume":"226","author":"Salvo","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib2395","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/S1470-2045(16)30032-8","article-title":"Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review","volume":"17","author":"Bentivegna","year":"2016","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2400","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ygyno.2011.08.009","article-title":"Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience","volume":"123","author":"Maneo","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib2405","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.fertnstert.2016.06.032","article-title":"Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature","volume":"106","author":"Bentivegna","year":"2016","journal-title":"Fertil Steril"},{"issue":"9815","key":"10.1016\/j.gofs.2025.07.005_bib2410","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0140-6736(11)60829-5","article-title":"Gynaecological cancers in pregnancy","volume":"379","author":"Morice","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2415","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clinimag.2012.04.004","article-title":"Management of cervical cancer detected during pregnancy: role of magnetic resonance imaging","volume":"37","author":"Balleyguier","year":"2013","journal-title":"Clin Imaging"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib2420","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jama.2016.12126","article-title":"Association between MRI exposure during pregnancy and fetal and childhood outcomes","volume":"316","author":"Ray","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2425","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/0284186X.2021.2004323","article-title":"Feasibility, safety and impact of (18F)-FDG PET\/CT in patients with pregnancy-associated cancer: experience of the French CALG (Cancer Associ\u00e9 \u00e0 La Grossesse) network","volume":"61","author":"Despierres","year":"2022","journal-title":"Acta Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib2430","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2967\/jnumed.121.263561","article-title":"(18)F-FDG fetal dosimetry calculated with PET\/MRI","volume":"63","author":"Zanotti-Fregonara","year":"2022","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2435","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/IGC.0000000000000062","article-title":"Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting","volume":"24","author":"Amant","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib2440","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/annonc\/mdz228","article-title":"Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting","volume":"30","author":"Amant","year":"2019","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib2445","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/medicina60040608","article-title":"Reproductive outcomes in young women with early-stage cervical cancer greater than 2cm undergoing fertility-sparing treatment: a systematic review","volume":"60","author":"D\u2019Amato","year":"2024","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib2450","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.3802\/jgo.2021.32.e83","article-title":"Fertility-sparing surgery for women with stage I cervical cancer of 4cm or larger: a systematic review","volume":"32","author":"Di Donato","year":"2021","journal-title":"J Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2025.07.005_bib2455","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/ijgc-2023-004669","article-title":"Fertility sparing therapy in women with lymph node negative cervical cancer>2cm\u00a0\u2013\u00a0oncologic and fertility outcomes of neoadjuvant chemotherapy followed by radical vaginal trachelectomy","volume":"33","author":"Plaikner","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib2460","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/ijgc-2019-000398","volume":"29","author":"Plante","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2465","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ygyno.2015.03.051","article-title":"Immediate radical trachelectomy versus neoadjuvant chemotherapy followed by conservative surgery for patients with stage IB1 cervical cancer with tumors 2cm or larger: a literature review and analysis of oncological and obstetrical outcomes","volume":"137","author":"Pareja","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2470","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ygyno.2019.09.025","article-title":"Abdominal radical trachelectomy versus chemotherapy followed by vaginal radical trachelectomy in stage 1B2 (FIGO 2018) cervical cancer. A systematic review on fertility and recurrence rates","volume":"155","author":"van Kol","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"35","key":"10.1016\/j.gofs.2025.07.005_bib2475","doi-asserted-by":"crossref","first-page":"59609","DOI":"10.18632\/oncotarget.19425","article-title":"Meta-analysis showing that early response to neoadjuvant chemotherapy predicts better survival among cervical cancer patients","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib2480","doi-asserted-by":"crossref","first-page":"e1051","DOI":"10.1634\/theoncologist.2020-0063","article-title":"Neoadjuvant chemotherapy followed by vaginal radical trachelectomy as fertility-preserving treatment for patients with FIGO 2018 stage 1B2 cervical cancer","volume":"25","author":"Zusterzeel","year":"2020","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2485","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ygyno.2015.05.043","article-title":"Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer","volume":"139","author":"Salihi","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2490","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/ijgc-2020-002076","article-title":"Oncological and obstetrical outcomes after neo-adjuvant chemotherapy followed by fertility-sparing surgery in patients with cervical cancer\u22652cm","volume":"31","author":"Rend\u00f3n","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2495","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/IGC.0000000000000080","article-title":"Radical vaginal trachelectomy after laparoscopic staging and neoadjuvant chemotherapy in women with early-stage cervical cancer over 2cm: oncologic, fertility, and neonatal outcome in a series of 20 patients","volume":"24","author":"Lanowska","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2500","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.suronc.2018.04.006","article-title":"NACT and laparoscopic-assisted radical vaginal trachelectomy in young patients with large (2\u20135cm) high risk cervical cancers: safety and obstetrical outcome","volume":"27","author":"Marchiol\u00e8","year":"2018","journal-title":"Surg Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2505","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2012.05.033","article-title":"Laparoscopic lymph node dissection should be performed before fertility preserving treatment of patients with cervical cancer","volume":"126","author":"Vercellino","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2510","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.fertnstert.2020.07.006","article-title":"Neoadjuvant chemotherapy followed by conization in stage IB2-IIA1 cervical cancer larger than 2cm: a pilot study","volume":"115","author":"de Vincenzo","year":"2021","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2515","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/ijgc-2019-000647","article-title":"Fertility-sparing surgery of cervical cancer>2cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy","volume":"30","author":"Tesfai","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"1\u00a0Suppl\u00a01","key":"10.1016\/j.gofs.2025.07.005_bib2520","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.ygyno.2007.07.011","article-title":"Chemo-conization in early cervical cancer","volume":"107","author":"Landoni","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2525","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ygyno.2021.06.006","article-title":"Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2\u20134cm; emerging data and future perspectives","volume":"162","author":"Gwacham","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2530","first-page":"38","article-title":"Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival","volume":"101","author":"Davy","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2535","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.fertnstert.2008.07.1714","article-title":"Effects of cancer treatment on ovarian function","volume":"92","author":"Stroud","year":"2009","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2540","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.fertnstert.2003.06.031","article-title":"Ovarian function preservation in the cancer patient","volume":"81","author":"Falcone","year":"2004","journal-title":"Fertil Steril"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.gofs.2025.07.005_bib2545","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.ejogrb.2003.11.008","article-title":"Ovarian function following radiation and chemotherapy for cancer","volume":"113","author":"Lo Presti","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2005.04.071","article-title":"Fertility preservation in female cancer patients: current developments and future directions","volume":"85","author":"Kim","year":"2006","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2555","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejogrb.2006.08.006","article-title":"The effect of cancer treatment on female fertility and strategies for preserving fertility","volume":"130","author":"Maltaris","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2025.07.005_bib2560","first-page":"77","article-title":"Evaluation of the hormonal function and features of the ultrasound picture of transposed ovary in cervical cancer patients after surgery and pelvic irradiation","volume":"14.\u00a0Suppl","author":"Bidzi\u0144ski","year":"1993","journal-title":"Eur J Gynaecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2565","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/gyno.1993.1109","article-title":"Ovarian transposition in cervical cancer","volume":"49","author":"Anderson","year":"1993","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2570","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ygyno.2006.12.001","article-title":"A new approach for laparoscopic ovarian transposition before pelvic irradiation","volume":"105","author":"Huang","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2575","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0015-0282(98)00155-1","article-title":"Laparoscopic ovarian suspension before irradiation","volume":"70","author":"Tulandi","year":"1998","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib2580","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jmig.2009.07.002","article-title":"Laparoscopic ovarian transposition with potential preservation of natural fertility","volume":"17","author":"Kwik","year":"2010","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.gofs.2025.07.005_bib2585","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211042140","article-title":"Ovarian function preservation in patients with cervical cancer undergoing hysterectomy and ovarian transposition before pelvic radiotherapy","volume":"20","author":"Jung","year":"2021","journal-title":"Technol Cancer Res Treat"},{"issue":"23","key":"10.1016\/j.gofs.2025.07.005_bib2590","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.21037\/atm-21-2909","article-title":"Significance of ovarian transposition in the preservation of ovarian function for young cervical cancer patients undergoing postoperative volumetric modulated radiotherapy","volume":"9","author":"Xu","year":"2021","journal-title":"Ann Transl Med"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib2595","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00404-018-4883-5","article-title":"Ovarian survival after pelvic radiation: transposition until the age of 35\u00a0years","volume":"298","author":"Hoekman","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2600","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13014-019-1437-3","article-title":"Association between the location of transposed ovary and ovarian dose in patients with cervical cancer treated with postoperative pelvic radiotherapy","volume":"14","author":"Lv","year":"2019","journal-title":"Radiat Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib2605","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.fertnstert.2012.02.052","article-title":"Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy","volume":"97","author":"Hwang","year":"2012","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2610","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9378(84)90368-5","article-title":"Stage IB adenocarcinoma of the cervix: metastatic potential and patterns of dissemination","volume":"150","author":"Kjorstad","year":"1984","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2615","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0090-8258(91)90253-2","article-title":"Microscopic ovarian metastasis of the uterine cervical cancer","volume":"41","author":"Toki","year":"1991","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2620","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0020-7292(97)02848-8","article-title":"Ovarian metastasis from cervical carcinoma","volume":"57","author":"Wu","year":"1997","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2625","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/gyno.1999.5442","article-title":"Ovarian metastasis in stage IB and II cervical adenocarcinoma","volume":"74","author":"Natsume","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib2630","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/ijc.31084","article-title":"Identifying a candidate population for ovarian conservation in young women with clinical stage IB-IIB cervical cancer","volume":"142","author":"Matsuo","year":"2018","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib2635","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0015-0282(00)01500-4","article-title":"Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination","volume":"74","author":"Morice","year":"2000","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2640","first-page":"623","article-title":"Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study)","volume":"17","author":"Landoni","year":"2007","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"10.1016\/j.gofs.2025.07.005_bib2645","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2273::AID-CNCR15>3.0.CO;2-C","article-title":"Is radical trachelectomy a safe alternative to radical hysterectomy for patients with stage IA-B carcinoma of the cervix?","volume":"86","author":"Covens","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2650","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/gyno.2000.5912","article-title":"Combined laparoscopic and vaginal radical surgery in cervical cancer","volume":"79","author":"Renaud","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2655","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ygyno.2007.03.009","article-title":"Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent's operation): a comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH)","volume":"106","author":"Marchiole","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2660","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.04.027","article-title":"Radical vaginal trachelectomy vs. radical hysterectomy for small early stage cervical cancer: a matched case-control study","volume":"110","author":"Beiner","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2665","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijgo.2010.08.020","article-title":"Systematic comparison of radical vaginal trachelectomy and radical hysterectomy in the treatment of early-stage cervical cancer","volume":"112","author":"Han","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2670","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/IGC.0000000000000012","article-title":"Pattern of cancer recurrence in 320 patients after radical vaginal trachelectomy","volume":"24","author":"Mangler","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2675","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2021.12.029","article-title":"Long term oncologic and reproductive outcomes after robot-assisted radical trachelectomy for early-stage cervical cancer. An international multicenter study","volume":"164","author":"Ekdahl","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2680","first-page":"62","article-title":"La pr\u00e9servation de fertilit\u00e9 en cas de cancer du col, analyse de 30\u00a0ans de pratique et immersion dans les \u00e9volutions \u00e0 venir [Fertility preservation in cervical cancer, analysis of 30 years of practice and immersion in future developments]","volume":"50","author":"Br\u00e9ban-Kehl","year":"2022","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2685","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12149-012-0659-3","article-title":"Early response of patients undergoing concurrent chemoradiotherapy for cervical cancer: a comparison of PET\/CT and MRI","volume":"27","author":"Lee","year":"2013","journal-title":"Ann Nucl Med"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2690","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1525-1438.1998.09759.x","article-title":"Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis","volume":"8","author":"Samlal","year":"1998","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2695","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/gyno.2000.5860","article-title":"Posttherapy surveillance of women with cervical cancer: an outcomes analysis","volume":"78","author":"Bodurka-Bevers","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib2700","doi-asserted-by":"crossref","first-page":"591253","DOI":"10.3389\/fonc.2020.591253","article-title":"Diagnostic strategies for recurrent cervical cancer: a cohort study","volume":"10","author":"Chao","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib2705","first-page":"23","article-title":"Int\u00e9r\u00eat des examens syst\u00e9matiques de suivi apr\u00e8s traitement radiochirurgical des cancers du col ut\u00e9rin aux stades I\/II","volume":"282","author":"Deyrolle","year":"2003","journal-title":"Lett Gyn"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2710","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/IGC.0000000000000835","article-title":"Sensitivity of follow-up methods in patients after fertility-sparing surgery for cervical cancers","volume":"27","author":"Slama","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cncr.23256","article-title":"Cytologic findings after fertility-sparing radical trachelectomy","volume":"114","author":"Feratovic","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2720","first-page":"106","article-title":"A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy","volume":"76","author":"Soisson","year":"1990","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.gofs.2025.07.005_bib2725","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1471-0528.1996.tb09600.x","article-title":"Recurrent stage IB cervical carcinoma: evaluation of the effectiveness of routine follow up surveillance","volume":"103","author":"Ansink","year":"1996","journal-title":"Br J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib2730","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1034\/j.1600-0412.2002.810414.x","article-title":"Recurrent cervical cancer: detection and prognosis","volume":"81","author":"Duyn","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib2735","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ijc.25741","article-title":"Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer","volume":"129","author":"Song","year":"2011","journal-title":"Int J Cancer"},{"issue":"20","key":"10.1016\/j.gofs.2025.07.005_bib2740","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.7150\/jca.46683","article-title":"Prognostic significance of negative conversion of high-risk human papillomavirus DNA after treatment in cervical cancer patients","volume":"11","author":"Chen","year":"2020","journal-title":"J Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2745","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.3802\/jgo.2020.31.e20","article-title":"Human papillomavirus (HPV) DNA detection in uterine cervix cancer after radiation indicating recurrence: a systematic review and meta-analysis","volume":"31","author":"Sabeena","year":"2020","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2750","doi-asserted-by":"crossref","first-page":"64","DOI":"10.6004\/jnccn.2019.0001","article-title":"Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Koh","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2755","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13244-022-01239-y","article-title":"What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?","volume":"13","author":"Lura","year":"2022","journal-title":"Insights Imaging"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2760","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/ijgc-2018-000168","article-title":"Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence","volume":"29","author":"Angeles","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib2765","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ejso.2020.10.009","article-title":"Prognosis impact of posttreatment pelvic MRI in patients treated for stage IB2-IIB cervical cancer with chemoradiation therapy","volume":"47","author":"Moussilmani","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2770","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00261-021-03288-1","article-title":"Magnetic resonance imaging-based texture analysis for the prediction of postoperative clinical outcome in uterine cervical cancer","volume":"47","author":"Kim","year":"2022","journal-title":"Abdom Radiol (NY)"},{"issue":"1136","key":"10.1016\/j.gofs.2025.07.005_bib2775","doi-asserted-by":"crossref","first-page":"20211229","DOI":"10.1259\/bjr.20211229","article-title":"MRI radiomics combined with clinicopathologic features to predict disease-free survival in patients with early-stage cervical cancer","volume":"95","author":"Jiang","year":"2022","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2780","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/IGC.0000000000000038","article-title":"Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival?","volume":"24","author":"Dhull","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"19","key":"10.1016\/j.gofs.2025.07.005_bib2785","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1001\/jama.298.19.2289","article-title":"Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma","volume":"298","author":"Schwarz","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib2790","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.3802\/jgo.2019.30.e66","article-title":"Prognostic value of post-treatment 18F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis","volume":"30","author":"Kim","year":"2019","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2795","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MNM.0000000000000026","article-title":"Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis","volume":"35","author":"Chu","year":"2014","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.gofs.2025.07.005_bib2800","doi-asserted-by":"crossref","first-page":"8874990","DOI":"10.1155\/2021\/8874990","article-title":"Diagnostic accuracy of 18F-FDG-PET\/CT and MRI in predicting the tumor response in locally advanced cervical carcinoma treated by chemoradiotherapy: a meta-analysis","volume":"2021","author":"Sanei Sistani","year":"2021","journal-title":"Contrast Media Mol Imaging"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2805","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00261-020-02633-0","article-title":"PET-detected asymptomatic recurrence is associated with improved survival in recurrent cervical cancer","volume":"46","author":"Peters","year":"2021","journal-title":"Abdom Radiol (NY)"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib2810","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00259-017-3898-7","article-title":"Prediction of outcome using pretreatment\u00a018F-FDG PET\/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy","volume":"45","author":"Lucia","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.gofs.2025.07.005_bib2815","first-page":"CD008767","article-title":"Follow-up protocols for women with cervical cancer after primary treatment","volume":"2013","author":"Lanceley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gofs.2025.07.005_bib2820","doi-asserted-by":"crossref","first-page":"8131","DOI":"10.2147\/CMAR.S314384","article-title":"Prognosis of early stage cervical cancer according to patterns of recurrence","volume":"13","author":"Chen","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.gofs.2025.07.005_bib2825","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejca.2021.09.008","article-title":"The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer","volume":"158","author":"Cibula","year":"2021","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib2830","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cncr.31165","article-title":"Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005\u20132013: a national cohort study","volume":"124","author":"Taarnh\u00f8j","year":"2018","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2835","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ygyno.2021.12.018","article-title":"Post-recurrence survival in patients with cervical cancer","volume":"164","author":"Cibula","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"27","key":"10.1016\/j.gofs.2025.07.005_bib2840","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2016.68.3789","article-title":"Management and care of women with invasive cervical cancer: ASCO resource-stratified clinical practice guideline","volume":"34","author":"Chuang","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2845","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3747\/co.23.2742","article-title":"Follow-up for cervical cancer: a program in evidence-based care systematic review and clinical practice guideline update","volume":"23","author":"Elit","year":"2016","journal-title":"Curr Oncol"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.gofs.2025.07.005_bib2850","doi-asserted-by":"crossref","first-page":"iv72","DOI":"10.1093\/annonc\/mdx220","article-title":"Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Marth","year":"2017","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2855","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.radonc.2018.03.003","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer","volume":"127","author":"Cibula","year":"2018","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2860","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2017.03.022","article-title":"An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations","volume":"146","author":"Salani","year":"2017","journal-title":"Gynecol Oncol"},{"year":"2022","series-title":"Cervical cancer [internet]","key":"10.1016\/j.gofs.2025.07.005_bib2865"},{"year":"2020","series-title":"D\u00e9pistage du cancer du col de l\u2019ut\u00e9rus\u00a0: le test HPV-HR recommand\u00e9 chez les femmes de plus de 30 ans [internet]","key":"10.1016\/j.gofs.2025.07.005_bib2870"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib2875","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s10147-020-01641-w","article-title":"Impact of a reduction in follow-up frequency on life expectancy in uterine cervical cancer patients","volume":"25","author":"Matsumoto","year":"2020","journal-title":"Int J Clin Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib2880","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1023\/A:1008356010556","article-title":"Concurrent carboplatin\/5-fluorouracil and radiotherapy for recurrent cervical carcinoma","volume":"10","author":"Maneo","year":"1999","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib2885","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/030089161009600407","article-title":"Feasibility and outcome of concurrent chemoradiotherapy for recurrent cervical carcinoma after initial surgery","volume":"96","author":"Lee","year":"2010","journal-title":"Tumori"},{"key":"10.1016\/j.gofs.2025.07.005_bib2890","doi-asserted-by":"crossref","first-page":"744871","DOI":"10.3389\/fonc.2021.744871","article-title":"Radiotherapy for vaginal recurrences of cervical cancer in patients after prior surgery: analysis of effect and prognostic factors","volume":"11","author":"Yan","year":"2021","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib2895","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1525-1438.1993.03040193.x","article-title":"Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery","volume":"3","author":"Thomas","year":"1993","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2900","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ygyno.2013.01.017","article-title":"The value of 18F-FDG PET\/CT in recurrent gynecologic malignancies prior to pelvic exenteration","volume":"129","author":"Burger","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib2905","doi-asserted-by":"crossref","first-page":"618485","DOI":"10.3389\/fonc.2021.618485","article-title":"Selection of treatment regimens for recurrent cervical cancer","volume":"11","author":"Chao","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2910","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ygyno.2019.03.104","article-title":"Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation","volume":"153","author":"Lin","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib2915","doi-asserted-by":"crossref","first-page":"683441","DOI":"10.3389\/fonc.2021.683441","article-title":"Laterally extended endopelvic resection versus chemo or targeted therapy alone for pelvic sidewall recurrence of cervical cancer","volume":"11","author":"Park","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2920","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2010.08.004","article-title":"Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery","volume":"119","author":"Ferrandina","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2925","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygyno.2005.10.011","article-title":"Total pelvic exenteration: the Albert Einstein College of Medicine\/Montefiore Medical Center Experience (1987 to 2003)","volume":"101","author":"Goldberg","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2930","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2009.09.035","article-title":"Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? A twenty-year experience","volume":"116","author":"Jurado","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"13","key":"10.1016\/j.gofs.2025.07.005_bib2935","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4103\/0366-6999.235111","article-title":"Pelvic exenteration for recurrent and persistent cervical cancer","volume":"131","author":"Li","year":"2018","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2940","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ygyno.2006.06.027","article-title":"Indications for primary and secondary exenterations in patients with cervical cancer","volume":"103","author":"Marnitz","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib2945","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1097\/IGC.0000000000000288","article-title":"Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer","volume":"24","author":"Sardain","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2950","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ygyno.2012.03.001","article-title":"Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer","volume":"125","author":"Schmidt","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2955","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10147-013-0534-9","article-title":"Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer","volume":"19","author":"Tanaka","year":"2014","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2960","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ygyno.2012.07.120","article-title":"(Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy","volume":"127","author":"H\u00f6ckel","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib2965","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2020.12.034","article-title":"Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: technical feasibility and short-term oncologic outcome","volume":"161","author":"Kanao","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2970","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ygyno.2020.03.006","article-title":"Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapy","volume":"157","author":"Mignot","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib2975","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/ijgc-2019-000615","article-title":"Para-aortic lymph node recurrence after curative radiotherapy for cervical cancer","volume":"29","author":"Cho","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib2980","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3802\/jgo.2012.23.3.168","article-title":"Salvage radiotherapy for lymph node recurrence after radical surgery in cervical cancer","volume":"23","author":"Jeon","year":"2012","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2985","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijrobp.2004.06.207","article-title":"Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence","volume":"61","author":"Singh","year":"2005","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib2990","doi-asserted-by":"crossref","first-page":"891","DOI":"10.21873\/anticanres.13190","article-title":"Radiation therapy for extrapelvic lymph node recurrence after curative treatment for cervical cancer","volume":"39","author":"Uno","year":"2019","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib2995","first-page":"5103","article-title":"Stereotactic body radiotherapy for recurrent or oligometastatic uterine cervix cancer: a Cooperative Study of the Korean Radiation Oncology Group (KROG 14-11)","volume":"35","author":"Park","year":"2015","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib3000","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0360-3016(02)04401-2","article-title":"Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix","volume":"55","author":"Kim","year":"2003","journal-title":"Int J Radiat Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib3005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/153303460900800510","article-title":"Stereotactic body radiosurgery for pelvic relapse of gynecologic malignancies","volume":"8","author":"Kunos","year":"2009","journal-title":"Technol Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib3010","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/ijgc-2021-002466","article-title":"Role of stereotactic body radiotherapy in gynecologic radiation oncology","volume":"32","author":"Shenker","year":"2022","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib3015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.gyobfe.2007.01.024","article-title":"Prise en charge chirurgicale par voie d\u2019abord c\u0153lioscopique du cancer du col ut\u00e9rin occulte d\u00e9couvert apr\u00e8s hyst\u00e9rectomie simple [Laparoscopic management of occult cervical cancer discovered after simple hysterectomy]","volume":"35","author":"Vignancour","year":"2007","journal-title":"Gynecol Obstet Fertil"},{"year":"2022","series-title":"Cancer du sol de l\u2019ut\u00e9rus\u00a0: la maladie [internet]","key":"10.1016\/j.gofs.2025.07.005_bib3020"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib3025","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/annonc\/mdp426","article-title":"Management of occult invasive cervical cancer found after simple hysterectomy","volume":"21","author":"Park","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib3030","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s12885-016-2480-1","article-title":"Occult invasive cervical cancer after simple hysterectomy: a multi-center retrospective study of 89 cases","volume":"16","author":"Bai","year":"2016","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib3035","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2018.02.015","article-title":"Radical parametrectomy after \u201ccut-through\u201d hysterectomy in low-risk early-stage cervical cancer: time to consider this procedure obsolete","volume":"149","author":"Pareja","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib3040","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1245\/s10434-014-4140-5","article-title":"Occult invasive cervical cancer found after inadvertent simple hysterectomy: is the ideal management: systematic parametrectomy with or without radiotherapy or radiotherapy only?","volume":"22","author":"Narducci","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib3045","first-page":"413","article-title":"Can radical parametrectomy be omitted in occult cervical cancer after extrafascial hysterectomy?","volume":"34","author":"Lu","year":"2015","journal-title":"Chin J Cancer"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib3050","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jmig.2017.02.016","article-title":"Robotic radical parametrectomy with upper vaginectomy and pelvic lymphadenectomy in patients with occult cervical carcinoma after extrafascial hysterectomy","volume":"24","author":"Tran","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib3055","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/IGC.0b013e3182681cd3","article-title":"Laparoscopic nerve-sparing radical parametrectomy for occult early-stage invasive cervical cancer after simple hysterectomy","volume":"22","author":"Li","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib3060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jso.20550","article-title":"Radical reoperation for invasive cervical cancer found in simple hysterectomy","volume":"94","author":"Ayhan","year":"2006","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib3065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2003.10.018","article-title":"The role of radical parametrectomy in the treatment of occult cervical carcinoma after extrafascial hysterectomy","volume":"92","author":"Leath","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib3070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijgo.2009.05.015","article-title":"Total laparoscopic radical parametrectomy, partial colpectomy, and pelvic lymphadenectomy in patients with occult cervical cancer","volume":"107","author":"Buda","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib3075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00128360-200404000-00004","article-title":"Radical parametrectomy for occult cervical carcinoma detected posthysterectomy","volume":"8","author":"Gori","year":"2004","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib3080","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jjco\/hyaa251","article-title":"Is salvage radiotherapy optimal to patients with occult cervical cancer undergoing inadvertent simple hysterectomy? A propensity score-matched analysis of a nationwide clinical oncology database","volume":"51","author":"Wang","year":"2021","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib3085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ygyno.2004.05.029","article-title":"Consequences of inadvertent, suboptimal primary surgery in carcinoma of the uterine cervix","volume":"94","author":"M\u00fcnstedt","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib3090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/COC.0b013e3181a6500d","article-title":"Postoperative radiotherapy for cervix cancer incidentally discovered after a simple hysterectomy for either benign conditions or noninvasive pathology","volume":"33","author":"Smith","year":"2010","journal-title":"Am J Clin Oncol"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib3095","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/annonc\/mdt142","article-title":"Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients","volume":"24","author":"Cetina","year":"2013","journal-title":"Ann Oncol"},{"year":"2013","series-title":"Perez and Brady's principles and practice of radiation oncology","author":"Halperin","key":"10.1016\/j.gofs.2025.07.005_bib3100"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib3105","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ijrobp.2015.11.024","article-title":"Image guided cervical brachytherapy: 2014 survey of the American Brachytherapy Society","volume":"94","author":"Grover","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib3110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.clon.2008.12.001","article-title":"Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator\u00a0\u2013\u00a0the Addenbrooke's experience","volume":"21","author":"Tan","year":"2009","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib3115","first-page":"e13789","article-title":"Cervical Stump cancer treated with radiotherapy using computed tomography-guided brachytherapy","volume":"13","author":"Okada","year":"2021","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib3120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0167-8140(97)01918-X","article-title":"Carcinoma of the cervical stump: retrospective analysis of 77 cases","volume":"43","author":"Hannoun-L\u00e9vi","year":"1997","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib3125","first-page":"568","volume":"82","author":"Pernot","year":"1995","journal-title":"Bull Cancer (Paris)"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib3130","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ijrobp.2013.06.2059","article-title":"Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study","volume":"87","author":"Gandhi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.gofs.2025.07.005_bib3135","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0959-8049(93)90063-L","article-title":"Carcinoma of the cervical stump: a review of 213 cases","volume":"29A","author":"Barillot","year":"1993","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib3140","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0090-8258(84)90012-X","article-title":"Carcinoma of the cervical stump","volume":"18","author":"Miller","year":"1984","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib3145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00404-002-0454-9","article-title":"Cervical stump cancer: a study of 14 cases","volume":"270","author":"Silva","year":"2004","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib3150","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1034\/j.1600-0412.2001.080002152.x","article-title":"Carcinoma of the cervical stump. The radiumhemmet series 1959\u20131987. Treatment and prognosis","volume":"80","author":"Hellstr\u00f6m","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib3155","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3802\/jgo.2018.29.e25","article-title":"Impact of adjuvant hysterectomy on prognosis in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy: a meta-analysis","volume":"29","author":"Shim","year":"2018","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib3160","first-page":"CD010260","article-title":"Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer","volume":"5","author":"Kokka","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.gofs.2025.07.005_bib3165","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jgyn.2010.09.009","volume":"39","author":"Touboul","year":"2010","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib3170","doi-asserted-by":"crossref","DOI":"10.1177\/0300060521992247","article-title":"Characteristics, complications, and outcomes of early-stage cervical stump carcinoma: laparoscopy versus laparotomy","volume":"49","author":"Lu","year":"2021","journal-title":"J Int Med Res"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib3175","first-page":"1651","article-title":"Carcinoma of the cervical stump: fifty years of experience","volume":"25","author":"Hellstr\u00f6m","year":"2011","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib3180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.maturitas.2014.04.018","article-title":"Cervical cancer in the older woman","volume":"78","author":"Elit","year":"2014","journal-title":"Maturitas"},{"year":"2008","series-title":"Donn\u00e9es \u00e9pid\u00e9miologiques sur le cancer du col de l\u2019ut\u00e9rus. Actualisation des connaissances 2008 [Internet]","author":"Invs","key":"10.1016\/j.gofs.2025.07.005_bib3185"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib3190","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ejca.2008.11.028","article-title":"The cancer survival gap between elderly and middle-aged patients in Europe is widening","volume":"45","author":"Quaglia","year":"2009","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib3195","first-page":"403","article-title":"To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study","volume":"33","author":"Compaor\u00e9","year":"2022","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib3200","doi-asserted-by":"crossref","DOI":"10.1177\/1073274820979590","article-title":"Cervical cancer among older women: analyses of surveillance, epidemiology and end results program data","volume":"27","author":"Quick","year":"2020","journal-title":"Cancer Control"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib3205","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12885-017-3503-2","article-title":"Outcome and toxicity of radical radiotherapy or concurrent chemoradiotherapy for elderly cervical cancer women","volume":"17","author":"Wang","year":"2017","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib3210","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.3802\/jgo.2018.29.e97","article-title":"Postoperative chemoradiotherapy versus radiotherapy alone for elderly cervical cancer patients with positive margins, lymph nodes, or parametrial invasion","volume":"29","author":"Cushman","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.gofs.2025.07.005_bib3215","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.2147\/CMAR.S190025","article-title":"Selective use of concurrent chemotherapy in elderly cervical cancer patients treated with definitive radiotherapy: experience from two institutions","volume":"11","author":"You","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"13","key":"10.1016\/j.gofs.2025.07.005_bib3220","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.26646","article-title":"Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score","volume":"118","author":"Extermann","year":"2012","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.gofs.2025.07.005_bib3225","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1089\/lap.2017.0022","article-title":"Laparoscopic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis","volume":"27","author":"Zhao","year":"2017","journal-title":"J Laparoendosc Adv Surg Tech A"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib3230","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jmig.2016.12.005","article-title":"Minimally invasive radical hysterectomy for cervical cancer is associated with reduced morbidity and similar survival outcomes compared with laparotomy","volume":"24","author":"Diver","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib3235","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2014.04.010","article-title":"Safety and tolerance of radical hysterectomy for cervical cancer in the elderly","volume":"134","author":"George","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib3240","first-page":"248","article-title":"Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: radiotherapy or surgery 1988\u20131995","volume":"97","author":"Brewster","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib3245","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ygyno.2005.03.017","article-title":"Comparison between conventional surgery and radiotherapy for FIGO stage I\u2013II cervical carcinoma: a retrospective Japanese study","volume":"97","author":"Yamashita","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib3250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.06.015","article-title":"Primary therapy for early-stage cervical cancer: radical hysterectomy vs. radiation","volume":"201","author":"Bansal","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib3255","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/COC.0b013e31826103d0","article-title":"Radical hysterectomy compared with primary radiation for treatment of stage IB1 cervix cancer","volume":"37","author":"Doll","year":"2014","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2025.07.005_bib3260","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000083681","article-title":"Feasibility of radical surgery in the management of elderly patients with uterine cervical cancer in Korea","volume":"59","author":"Choi","year":"2005","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.gofs.2025.07.005_bib3265","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1477-7819-6-38","article-title":"Radical hysterectomy in the elderly","volume":"6","author":"Mousavi","year":"2008","journal-title":"World J Surg Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib3270","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.radonc.2014.11.045","article-title":"Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy","volume":"114","author":"Mazeron","year":"2015","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib3275","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ygyno.2016.08.317","article-title":"Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology\/Gynecologic Oncology Group ancillary data analysis","volume":"143","author":"Moore","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"14","key":"10.1016\/j.gofs.2025.07.005_bib3280","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1002\/cncr.26589","article-title":"Patterns of care and treatment outcomes for elderly women with cervical cancer","volume":"118","author":"Sharma","year":"2012","journal-title":"Cancer"},{"issue":"3\u20134","key":"10.1016\/j.gofs.2025.07.005_bib3285","first-page":"309","article-title":"Prognostic factors in definitive radiotherapy of uterine cervical cancer","volume":"24","author":"Yalman","year":"2003","journal-title":"Eur J Gynaecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib3290","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jgo.2016.12.004","article-title":"Patterns of care of cervical cancer in the elderly: a qualitative literature review","volume":"8","author":"Venkatesulu","year":"2017","journal-title":"J Geriatr Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2025.07.005_bib3295","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/jog.12387","article-title":"Major causes of impractical brachytherapy in elderly patients with uterine cervical cancer","volume":"40","author":"Yanazume","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"10.1016\/j.gofs.2025.07.005_bib3300","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2008.08.011","article-title":"Patterns of care and outcome in elderly cervical cancer patients: a special focus on brachytherapy","volume":"91","author":"Magn\u00e9","year":"2009","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib3305","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jjco\/hyg041","article-title":"High dose-rate brachytherapy for elderly patients with uterine cervical cancer","volume":"33","author":"Chen","year":"2003","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib3310","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-8140(00)00168-7","article-title":"Radiotherapy in the management of cervical cancer in elderly patients","volume":"56","author":"Lindegaard","year":"2000","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib3315","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4097\/kjae.2009.56.4.398","article-title":"The hemodynamic effects of a reversed Trendelenburg in elderly patients with increased cardiac risk during laparoscopic cholecystectomy","volume":"56","author":"Kim","year":"2009","journal-title":"Korean J Anesthesiol"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib3320","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5114\/jcb.2018.79334","article-title":"The analysis of the long-term outcomes in elderly women treated for locally advanced cervical cancer","volume":"10","author":"Koper","year":"2018","journal-title":"J Contemp Brachytherapy"},{"issue":"5","key":"10.1016\/j.gofs.2025.07.005_bib3325","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jmig.2018.01.007","article-title":"Robotic surgery in elderly and very elderly gynecologic cancer patients","volume":"25","author":"Gallotta","year":"2018","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.gofs.2025.07.005_bib3330","doi-asserted-by":"crossref","first-page":"101976","DOI":"10.1016\/j.ctrv.2020.101976","article-title":"Challenges and advances in cervix cancer treatment in elder women","volume":"84","author":"Kissel","year":"2020","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"10.1016\/j.gofs.2025.07.005_bib3335","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/gerona\/63.7.724","article-title":"Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?","volume":"63","author":"Girre","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"27","key":"10.1016\/j.gofs.2025.07.005_bib3340","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1200\/JCO.2010.31.0664","article-title":"Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study","volume":"29","author":"Caillet","year":"2011","journal-title":"J Clin Oncol"},{"year":"2007","series-title":"Berek & Novak's gynecology","author":"Berek","key":"10.1016\/j.gofs.2025.07.005_bib3345"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib3350","first-page":"12","article-title":"Carcinoma of the cervix in association with procidentia","volume":"24","author":"Edwards","year":"1950","journal-title":"Q Bull Northwest Univ Med Sch"},{"issue":"1","key":"10.1016\/j.gofs.2025.07.005_bib3355","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00192-015-2731-8","article-title":"Treatment patterns and survival outcomes in patients with cervical cancer complicated by complete uterine prolapse: a systematic review of literature","volume":"27","author":"Matsuo","year":"2016","journal-title":"Int Urogynecol J"},{"issue":"4","key":"10.1016\/j.gofs.2025.07.005_bib3360","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.21873\/invivo.12010","article-title":"Radical hysterectomy for cervical cancer in patients with uterine prolapse","volume":"34","author":"Bacalbasa","year":"2020","journal-title":"In Vivo"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718925001916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718925001916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T11:45:32Z","timestamp":1756727132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718925001916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":672,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2468718925001916"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2025.07.005","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Le cancer du col de l\u2019ut\u00e9rus\u00a0: recommandations pour la pratique clinique","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2025.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}